<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="pmc-domain-id">1692</journal-id><journal-id journal-id-type="pmc-domain">nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430409</article-id><article-id pub-id-type="pmcid-ver">PMC12430409.1</article-id><article-id pub-id-type="pmcaid">12430409</article-id><article-id pub-id-type="pmcaiid">12430409</article-id><article-id pub-id-type="doi">10.3390/nu17172860</article-id><article-id pub-id-type="publisher-id">nutrients-17-02860</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Creatine Supplementation Combined with Exercise in the Prevention of Type 2 Diabetes: Effects on Insulin Resistance and Sarcopenia</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6799-4746</contrib-id><name name-style="western"><surname>M&#322;ynarska</surname><given-names initials="E">Ewelina</given-names></name><xref rid="af1-nutrients-17-02860" ref-type="aff">1</xref><xref rid="c1-nutrients-17-02860" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0001-6985-7008</contrib-id><name name-style="western"><surname>Leszto</surname><given-names initials="K">Klaudia</given-names></name><xref rid="af1-nutrients-17-02860" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kata&#324;ska</surname><given-names initials="K">Kinga</given-names></name><xref rid="af1-nutrients-17-02860" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Prusak</surname><given-names initials="A">Aleksandra</given-names></name><xref rid="af1-nutrients-17-02860" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wieczorek</surname><given-names initials="A">Anna</given-names></name><xref rid="af1-nutrients-17-02860" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0004-0358-9065</contrib-id><name name-style="western"><surname>Jakubowska</surname><given-names initials="P">Paulina</given-names></name><xref rid="af1-nutrients-17-02860" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rysz</surname><given-names initials="J">Jacek</given-names></name><xref rid="af2-nutrients-17-02860" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Franczyk</surname><given-names initials="B">Beata</given-names></name><xref rid="af2-nutrients-17-02860" ref-type="aff">2</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Kitagawa</surname><given-names initials="N">Noriyuki</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-nutrients-17-02860"><label>1</label>Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland</aff><aff id="af2-nutrients-17-02860"><label>2</label>Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland</aff><author-notes><corresp id="c1-nutrients-17-02860"><label>*</label>Correspondence: <email>emmlynarska@gmail.com</email>; Tel.: +48-(042)-639-37-50</corresp></author-notes><pub-date pub-type="epub"><day>03</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>17</volume><issue>17</issue><issue-id pub-id-type="pmc-issue-id">495755</issue-id><elocation-id>2860</elocation-id><history><date date-type="received"><day>13</day><month>8</month><year>2025</year></date><date date-type="rev-recd"><day>30</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>01</day><month>9</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>03</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 11:25:14.803"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nutrients-17-02860.pdf"/><abstract><p>Type 2 diabetes (T2D) is a chronic metabolic disorder marked by insulin resistance and impaired glucose metabolism, with skeletal muscle being a major site of systemic glucose disposal. This review examines the bidirectional relationship between T2D and sarcopenia, and synthesizes current evidence on how skeletal muscle deterioration and insulin resistance interact to disrupt glucose homeostasis. We summarize molecular mechanisms by which physical exercise enhances glucose uptake via insulin-dependent and insulin-independent pathways, and review the ergogenic and metabolic effects of creatine monohydrate (CrM). We also evaluate studies combining CrM supplementation with resistance or aerobic training and their effects on glycaemic control, muscle mass and function. Overall, combined exercise and creatine supplementation show potential to improve glucose regulation and attenuate muscle loss in older adults and people with T2D. Available data indicate that CrM is well tolerated in healthy and clinical populations when used at recommended doses, with no consistent evidence of adverse renal or hepatic effects. Further large randomized trials are needed to define optimal dosing, training modalities and long-term benefits for metabolic outcomes.</p></abstract><kwd-group><kwd>exercise</kwd><kwd>creatine</kwd><kwd>type 2 diabetes</kwd><kwd>insulin resistant</kwd><kwd>skeletal muscle mass</kwd><kwd>sarcopenia</kwd></kwd-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-nutrients-17-02860"><title>1. Introduction</title><p>Persistent hyperglycemia is a hallmark of type 2 diabetes (T2D), a chronic metabolic disease. It may result from decreased insulin secretion, reduced sensitivity to insulin in peripheral tissues (insulin resistance), or a combination of both [<xref rid="B1-nutrients-17-02860" ref-type="bibr">1</xref>,<xref rid="B2-nutrients-17-02860" ref-type="bibr">2</xref>]. In the early stages, the pancreas compensates for insulin resistance by increasing insulin production. However, over time, this compensatory mechanism fails, insulin levels decline, and T2D develops [<xref rid="B3-nutrients-17-02860" ref-type="bibr">3</xref>].</p><p>Although T2D has traditionally affected adults over the age of 45, its prevalence is increasing among children, adolescents, and young adults, driven by rising rates of obesity, sedentary lifestyles, and consumption of energy-dense foods [<xref rid="B4-nutrients-17-02860" ref-type="bibr">4</xref>].</p><p>According to the International Diabetes Federation (IDF) Diabetes Atlas 2025, an estimated 11.1% of the global adult population aged 20&#8211;79 years is currently living with diabetes. The most significant increases have been observed in low- and middle-income countries (LMICs), where access to diagnosis and treatment remains limited [<xref rid="B5-nutrients-17-02860" ref-type="bibr">5</xref>]. Globally, nearly 500 million individuals are currently living with T2D, and its prevalence doubled between 1990 and 2022 [<xref rid="B6-nutrients-17-02860" ref-type="bibr">6</xref>,<xref rid="B7-nutrients-17-02860" ref-type="bibr">7</xref>]. Projections estimate that by 2050, the total number of people living with diabetes will reach 853 million [<xref rid="B5-nutrients-17-02860" ref-type="bibr">5</xref>].</p><p>Beyond its direct connection to insulin resistance, T2D is increasingly recognized as closely linked with musculoskeletal decline, particularly sarcopenia&#8212;the progressive loss of skeletal muscle mass and strength, which frequently coexists with T2D [<xref rid="B8-nutrients-17-02860" ref-type="bibr">8</xref>,<xref rid="B9-nutrients-17-02860" ref-type="bibr">9</xref>]. This coexistence carries important clinical implications, as sarcopenia reduces muscle-mediated glucose uptake, thereby worsening insulin resistance [<xref rid="B10-nutrients-17-02860" ref-type="bibr">10</xref>]. Conversely, insulin resistance impairs anabolic signaling and promotes muscle catabolism, accelerating muscle loss [<xref rid="B11-nutrients-17-02860" ref-type="bibr">11</xref>,<xref rid="B12-nutrients-17-02860" ref-type="bibr">12</xref>]. Such a bidirectional relationship worsens metabolic health and increases the risk of T2D progression [<xref rid="B13-nutrients-17-02860" ref-type="bibr">13</xref>].</p><p>Epidemiological studies consistently demonstrate a high prevalence of sarcopenia among individuals with T2D. In a hospital-based study of 334 patients with T2D, 30.2% were diagnosed with sarcopenia [<xref rid="B14-nutrients-17-02860" ref-type="bibr">14</xref>]. Similarly, a cross-sectional analysis of 6381 individuals over the age of 50 reported sarcopenia in 28% of participants with T2D compared with 16% in non-diabetic individuals [<xref rid="B15-nutrients-17-02860" ref-type="bibr">15</xref>]. These findings suggest a non-random association, underpinned by shared pathophysiological mechanisms, such as insulin resistance, chronic inflammation, and mitochondrial dysfunction [<xref rid="B16-nutrients-17-02860" ref-type="bibr">16</xref>].</p><p>This overlap opens a potential therapeutic target. Interventions aimed at preserving or increasing muscle mass, such as resistance training, adequate protein intake, and anabolic agents, have shown potential in improving insulin sensitivity and glycemic control [<xref rid="B16-nutrients-17-02860" ref-type="bibr">16</xref>,<xref rid="B17-nutrients-17-02860" ref-type="bibr">17</xref>]. For example, a meta-analysis of supervised aerobic exercise programs (&gt;12 weeks) found that 87.5% of interventions led to reductions in glycosylated hemoglobin (HbA1c) [<xref rid="B18-nutrients-17-02860" ref-type="bibr">18</xref>]. In other studies, 10 weeks of resistance training in patients with T2D resulted in an 18% reduction in HbA1c [<xref rid="B19-nutrients-17-02860" ref-type="bibr">19</xref>].</p><p>Integrating muscle-preserving strategies into diabetes management may therefore offer significant added value. Given the central role of muscle in glucose metabolism, creatine supplementation, a well-established tool in sports nutrition, has attracted growing interest for its potential role in improving insulin sensitivity and counteracting sarcopenia [<xref rid="B20-nutrients-17-02860" ref-type="bibr">20</xref>,<xref rid="B21-nutrients-17-02860" ref-type="bibr">21</xref>]. A schematic summary of the proposed mechanisms linking creatine and exercise to improved muscle and metabolic outcomes is presented in <xref rid="nutrients-17-02860-f001" ref-type="fig">Figure 1</xref>.</p><p>A 2011 study showed that individuals with T2D who combined creatine supplementation with exercise experienced greater improvements in insulin sensitivity compared with those who exercised without supplementation. Creatine supplementation, as demonstrated in this study, can improve glycemic control by enhancing GLUT-4 translocation in skeletal muscle. This effect occurred without between-group differences in muscle mass or strength, suggesting a mechanism independent of hypertrophy [<xref rid="B22-nutrients-17-02860" ref-type="bibr">22</xref>]. Together, these data support a dual perspective for T2D management: (1) interventions that counteract sarcopenia can improve glycemic control, and (2) creatine may provide additional benefit even when hypertrophy is limited by enhancing glucose transport in skeletal muscle when used alongside exercise [<xref rid="B23-nutrients-17-02860" ref-type="bibr">23</xref>,<xref rid="B24-nutrients-17-02860" ref-type="bibr">24</xref>,<xref rid="B25-nutrients-17-02860" ref-type="bibr">25</xref>].</p><p>Given the association between increased skeletal muscle mass, improved glycemic control, and enhanced insulin sensitivity, creatine represents a promising adjunct in T2D management and in reducing diabetes risk, especially when combined with exercise.</p><p>Despite promising evidence, the potential of creatine supplementation in T2D management remains limited, particularly in the context of sarcopenia.</p><p>The aim of this narrative review is to analyze the interplay between insulin resistance and sarcopenia in the pathophysiology of T2D, and to evaluate the therapeutic potential of muscle-preserving interventions&#8212;particularly exercise and creatine supplementation&#8212;in managing T2D and preventing its progression.</p><p>Building on prior studies, we add and integrate several significant elements: (1) an integration of bidirectional link between sarcopenia and T2D and an appraisal of the creatine&#8211;exercise combination as a muscle preserving adjunct in metabolic care, including discussion of molecular and pathophysiological mechanisms underlying creatine&#8217;s effects, alongside evidence on its impact on sarcopenia, glucose homeostasis, and insulin resistance; (2) a synthesis of trials on creatine-exercise combinations and their effects in patients with T2D, older adults, and healthy volunteers, summarized in a single table; (3) a clinical interpretation of the safety profile, including dosing strategies; and (4) an assessment of creatine forms and co-ingestion interactions (e.g., caffeine, selected drugs) relevant to metabolic care.</p></sec><sec id="sec2-nutrients-17-02860"><title>2. The Role of Creatine in Energy Metabolism, Sarcopenia, and Its Impact on Glucose Metabolism</title><sec id="sec2dot1-nutrients-17-02860"><title>2.1. The Role of Creatine in Energy Metabolism</title><p>Creatine, chemically known as <italic toggle="yes">N</italic>-aminoiminomethyl-<italic toggle="yes">N</italic>-methylglycine, is primarily synthesized endogenously in the kidneys and liver from the amino acids arginine and glycine. Approximately 50% of the daily creatine requirement is supplied by endogenous synthesis, with the remainder obtained from diet or supplementation. About 95% of creatine in the body is stored in skeletal muscles, primarily as phosphocreatine (PCr), which, in conjunction with creatine kinase (CK), facilitates ATP regeneration&#8212;the primary energy carrier in cells. Creatine is transported into cells via specific transporters (CRTRs) and functions additionally as an antioxidant, mitigating mitochondrial oxidative stress. Between 1&#8211;2% of muscle creatine is converted into creatinine and subsequently excreted in urine; this conversion positively correlates with increased muscle mass and physical activity [<xref rid="B26-nutrients-17-02860" ref-type="bibr">26</xref>].</p><p>Besides facilitating rapid ATP regeneration during high-intensity exercise, PCr supports intracellular transport of high-energy phosphates between synthesis and utilization sites. It participates in buffering intracellular acidification by consuming hydrogen ions [<xref rid="B27-nutrients-17-02860" ref-type="bibr">27</xref>].</p></sec><sec id="sec2dot2-nutrients-17-02860"><title>2.2. Creatine in Sarcopenia and Its Effect on Glucose Metabolism</title><p>Sarcopenia is characterized by progressive loss of muscle mass, strength, and functional capacity [<xref rid="B28-nutrients-17-02860" ref-type="bibr">28</xref>]. It primarily affects elderly individuals, with a multifactorial etiology involving factors such as physical inactivity, chronic diseases, genetic predisposition, decreased caloric intake, hormonal imbalance, and metabolic disturbances [<xref rid="B29-nutrients-17-02860" ref-type="bibr">29</xref>]. Increasing evidence suggests that sarcopenia also impacts glucose metabolism, contributing to insulin resistance and T2D [<xref rid="B28-nutrients-17-02860" ref-type="bibr">28</xref>].</p><p>Aging is accompanied by an imbalance between anabolic and catabolic muscle protein pathways, resulting in net muscle mass loss. A decrease occurs in both the size and number of muscle fibers, particularly type II fibers, owing to their transition into type I fibers, alongside infiltration by intra- and inter-muscular fat and a reduction in type II fiber satellite cells. Pathogenic crosstalk between adipose tissue and muscle is also significant. Dysfunction of adipose tissue, including adipocyte hypertrophy, overproduction of lipids and adipokines, and chronic inflammation, leads to lipid accumulation in muscles, mitochondrial dysfunction, oxidative stress, and insulin resistance. Adipose tissue and muscle communicate through cytokines, chemokines, adipokines, and myokines, creating a self-perpetuating inflammatory&#8211;metabolic loop that promotes the development of sarcopenic obesity [<xref rid="B30-nutrients-17-02860" ref-type="bibr">30</xref>].</p><p>Molecularly, mitochondrial dysfunction is characterized by excessive reactive oxygen species (ROS) production, AMP-activated protein kinase (AMPK) pathway activation, and reduced expression and activity of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1&#945;). Consequently, chronic activation of nuclear factor kappa-B (NF-&#954;B) and p38 mitogen-activated protein kinase (p38 MAPK) pathways occurs, leading to prolonged muscle protein degradation and weakness.</p><p>Chronic inflammation, marked by increased pro-inflammatory cytokines (e.g., tumor necrosis factor alpha (TNF-&#945;), interleukin-1 beta (IL-1&#946;)), signal transducer and activator of transcription 1/3 (STAT1/3) pathway activation, and excessive glucocorticoid receptor stimulation, promotes muscle fiber damage and impaired regeneration. Hormonal disturbances, such as insulin-like growth factor 1 (IGF-1) resistance, dysfunction of the growth hormone (GH)/IGF-1 axis, and impaired androgen signaling, further hinder muscle regeneration and adaptation. Moreover, heightened proteolytic activity (e.g., caspase-3-mediated), suppression of protein synthesis via mechanistic target of rapamycin complex 1 (mTORC1) signaling attenuation, satellite cell dysfunction, and cytoskeletal alterations accelerate muscle atrophy progression [<xref rid="B31-nutrients-17-02860" ref-type="bibr">31</xref>].</p><p>Regarding carbohydrate metabolism, reduced skeletal muscle mass diminishes the body&#8217;s capacity to take up and store glucose. This leads to insulin resistance and hyperglycemia [<xref rid="B28-nutrients-17-02860" ref-type="bibr">28</xref>]. Muscles produce myokines released during physical activity, which support glucose metabolism by enhancing insulin sensitivity and additionally exert anti-inflammatory effects, inhibit lipid accumulation, and counteract sarcopenia progression, thereby reducing the risk of type 2 diabetes [<xref rid="B32-nutrients-17-02860" ref-type="bibr">32</xref>].</p><p>Creatine supplementation may effectively preserve muscle mass and function in older adults, thereby playing a key role in sarcopenia prevention and mitigating its adverse health impacts [<xref rid="B33-nutrients-17-02860" ref-type="bibr">33</xref>]. Additionally, creatine may contribute to blood glucose regulation, important for preventing T2D in elderly populations. Clinical evidence remains limited, comprising a few short-term studies insufficient to support widespread practical application of creatine supplementation. In the review by Solis M. et al., it was emphasized that basic research suggests possible mechanisms, including creatine&#8217;s potential to stimulate insulin secretion in vitro and increase muscle glycogen stores, with the most effective intervention combining supplementation with physical exercise, thereby enhancing glucose transport to the sarcolemma via translocation of glucose transporter type 4 (GLUT4) [<xref rid="B34-nutrients-17-02860" ref-type="bibr">34</xref>].</p></sec></sec><sec id="sec3-nutrients-17-02860"><title>3. The Role of Physical Exercise in Improving Glucose Metabolism</title><sec id="sec3dot1-nutrients-17-02860"><title>3.1. Molecular Mechanisms of Glucose Regulation in Skeletal Muscle</title><p>Skeletal muscle plays a critical role in the maintenance of postprandial glucose homeostasis, with over 80% of glucose being transported into skeletal muscle via insulin-dependent mechanisms [<xref rid="B35-nutrients-17-02860" ref-type="bibr">35</xref>,<xref rid="B36-nutrients-17-02860" ref-type="bibr">36</xref>,<xref rid="B37-nutrients-17-02860" ref-type="bibr">37</xref>]. Under hyperglycemic conditions, this proportion may increase to over 90% of insulin-mediated glucose uptake [<xref rid="B38-nutrients-17-02860" ref-type="bibr">38</xref>].</p><p>Following a meal, elevated insulin levels bind to insulin receptors, triggering phosphorylation of the insulin receptor substrate (IRS) and activation of the protein kinase B (Akt/PKB) pathway. As a result, GLUT4 is translocated from the cytosol to the sarcolemma, facilitating glucose entry by facilitated diffusion [<xref rid="B35-nutrients-17-02860" ref-type="bibr">35</xref>].</p><p>In addition to insulin signaling, skeletal muscle contractions promote GLUT4 translocation via distinct, insulin-independent mechanisms, including Ras-related C3 Botulinum Toxin substrate 1 (Rac1)/actin and Ca<sup>2+</sup>/calmodulin-dependent protein kinase (CaMK), thereby enhancing glucose uptake during and after exercise [<xref rid="B35-nutrients-17-02860" ref-type="bibr">35</xref>,<xref rid="B39-nutrients-17-02860" ref-type="bibr">39</xref>].</p><p>In patients with T2D, both GLUT4 abundance and its translocation are compromised due to insulin resistance. Overnutrition, resulting in lipid overload, reduces insulin-stimulated glucose disposal [<xref rid="B40-nutrients-17-02860" ref-type="bibr">40</xref>,<xref rid="B41-nutrients-17-02860" ref-type="bibr">41</xref>]. Moreover, lipid intermediates accumulate and act as signaling molecules influencing skeletal muscle peroxisomal metabolism, oxidative phosphorylation and insulin signaling [<xref rid="B42-nutrients-17-02860" ref-type="bibr">42</xref>]. Furthermore, they enhance the activity of protein kinase C&#952;, causing inhibitory serine phosphorylation of the insulin receptor and IRS, which suppresses their function [<xref rid="B43-nutrients-17-02860" ref-type="bibr">43</xref>].</p><p>Insulin-dependent GLUT4-mediated glucose uptake is severely impaired in insulin-resistant skeletal muscle. Nevertheless, exercise-induced glucose clearance is relatively preserved in individuals with T2D, highlighting its potential importance in novel diabetes management strategies [<xref rid="B44-nutrients-17-02860" ref-type="bibr">44</xref>]. Notably, endurance exercise training promotes an increase in the amount of GLUT4 transporter within skeletal muscles, thereby improving glucose uptake and overall muscle metabolism [<xref rid="B39-nutrients-17-02860" ref-type="bibr">39</xref>].</p><p>While impairments in insulin signaling and GLUT4 translocation significantly contribute to disrupted glucose uptake in skeletal muscles in T2D, it is important to emphasize that mitochondrial dysfunction also plays a pivotal role in the pathophysiology of insulin resistance.</p><p>In the context of T2D, the nutrient overload triggers high protonmotive force and oxidative stress [<xref rid="B45-nutrients-17-02860" ref-type="bibr">45</xref>], and creates a high H2O2-emitting potential [<xref rid="B46-nutrients-17-02860" ref-type="bibr">46</xref>]. The redox imbalance resulting from an increase in ROS levels or insufficient endogenous antioxidant capacity seems to play a crucial role in the development and progression of T2D [<xref rid="B47-nutrients-17-02860" ref-type="bibr">47</xref>].</p><p>T2D has been associated with mitochondrial abnormalities, including reduced size, morphological damage, and impaired functionality [<xref rid="B48-nutrients-17-02860" ref-type="bibr">48</xref>]. Meex et al. demonstrated that combined aerobic and resistance training lasting 12 weeks led to a recovery of mitochondrial function approaching the values seen in healthy control subjects. In individuals with T2D, this mitochondrial improvement was accompanied by a partial enhancement in insulin-stimulated glucose uptake and a full normalization of both metabolic flexibility and insulin-driven substrate oxidation to values comparable to those of controls [<xref rid="B49-nutrients-17-02860" ref-type="bibr">49</xref>]. Regular physical activity modulates the oxidative balance in cells and tissues by enhancing antioxidant defense and minimizing oxidative damage induced by ROS [<xref rid="B50-nutrients-17-02860" ref-type="bibr">50</xref>].</p></sec><sec id="sec3dot2-nutrients-17-02860"><title>3.2. Role of Exercise in Type 2 Diabetes Management</title><p>Physical activity represents a first-line strategy in the prevention and management of T2D. According to World Health Organization (WHO) Guidelines on Physical Activity and Sedentary Behaviour [<xref rid="B51-nutrients-17-02860" ref-type="bibr">51</xref>], adults living with T2D are advised to engage in either 150&#8211;300 min of moderate-intensity aerobic physical activity or 75&#8211;150 min vigorous-intensity aerobic physical activity per week, complemented by muscle-strengthening resistance training on two or more days per week. Exceeding the recommended values is associated with additional health benefits.</p><p>Aerobic exercise is defined as sustained and rhythmic physical activity that involves large muscle groups and can be performed continuously over an extended period [<xref rid="B52-nutrients-17-02860" ref-type="bibr">52</xref>,<xref rid="B53-nutrients-17-02860" ref-type="bibr">53</xref>]. Aerobic exercises include activities such as walking, cycling, or swimming. Numerous scientific studies support the efficacy of aerobic training in improving glucose regulation, specifically fasting glucose levels and HbA1c [<xref rid="B54-nutrients-17-02860" ref-type="bibr">54</xref>]. The population-based cohort study by Cuthbertson et al. assessing the correlation between the number of steps per day and the risk of developing T2D showed that accumulating more steps/day and walking with increased stepping pace contribute to a lower risk of developing T2D [<xref rid="B55-nutrients-17-02860" ref-type="bibr">55</xref>]. This finding seems consistent with the prospective cohort study on physical activity patterns and T2D incidence by Liao et al. The study examined the relationship between the duration and consistency of moderate-to-vigorous physical activity and the risk of T2D progression. The results show that a longer duration of physical activity is associated with a gradual reduction in the T2D incidence both for the regular activity group and weekend warriors. Moreover, exceeding the guideline-recommended physical activity levels results in further risk reduction [<xref rid="B56-nutrients-17-02860" ref-type="bibr">56</xref>]. Similar conclusions can be drawn from the population-based prospective cohort study conducted by Li et al., which demonstrated that both the volume and intensity of physical activity are inversely associated with T2D. While higher overall physical activity volume reduces T2D risk, engaging in higher-intensity physical activity provides additional protective benefits. Furthermore, vigorous physical activity offers the greatest benefit in lowering T2D incidence [<xref rid="B57-nutrients-17-02860" ref-type="bibr">57</xref>]. It is therefore unsurprising that aerobic training is the most frequently advocated form of exercise in physical activity guidelines worldwide [<xref rid="B58-nutrients-17-02860" ref-type="bibr">58</xref>].</p><p>While aerobic training is widely endorsed in physical activity recommendations, only a subset of standards identifies strength exercise as an important factor influencing glucose homeostasis [<xref rid="B58-nutrients-17-02860" ref-type="bibr">58</xref>]. Resistance training comprises movements performed against external resistance, such as free weights, weight machines, body weight or resistance bands [<xref rid="B52-nutrients-17-02860" ref-type="bibr">52</xref>]. The studies indicate that resistance training induced an increase in mitochondrial content [<xref rid="B59-nutrients-17-02860" ref-type="bibr">59</xref>], glucose extraction, and GLUT4 density [<xref rid="B60-nutrients-17-02860" ref-type="bibr">60</xref>] in trained muscles in individuals with T2D. The controlled trial conducted by Chien et al. showed that a 12-week strength exercise program led to improvements in HbA1c, extremity strength, and muscle mass in patients with T2D and possible sarcopenia [<xref rid="B61-nutrients-17-02860" ref-type="bibr">61</xref>]. A notable correlation has been observed between enhanced muscle strength from resistance training and glucose homeostasis. The meta-analysis of 20 studies revealed that improvements in muscular strength due to training significantly influenced HbA1c, with larger gains correlating with greater reductions [<xref rid="B62-nutrients-17-02860" ref-type="bibr">62</xref>].</p></sec><sec id="sec3dot3-nutrients-17-02860"><title>3.3. Combined Training as an Optimal Intervention Strategy</title><p>Although both aerobic and resistance training independently improve glycemic regulation, evidence suggests that a combined approach is more effective. This potential additive effect of aerobic and strength exercise has been supported by a meta-analysis of 37 studies. Various exercise modalities, including combined exercise, supervised aerobic, supervised resistance, unsupervised aerobic, and unsupervised resistance, were compared in the analysis. The results show that combined training has the greatest potential in the reduction of HbA1c [<xref rid="B63-nutrients-17-02860" ref-type="bibr">63</xref>]. Comparable results come from controlled trials performed by Amaravadi et al. The intervention group participated in a 12-week structured training program including walking and strength exercises for both upper and lower limbs, while the control group was advised to follow standard hospital care. The study group demonstrated significant improvements in metabolic outcomes, including insulin resistance, fasting, and postprandial glucose levels and HbA1c, which support the conclusion that combined training is an effective way to maintain glucose homeostasis [<xref rid="B64-nutrients-17-02860" ref-type="bibr">64</xref>]. These results correspond with those reported by Liu et al., who demonstrated a progressive decrease in glucose values in study groups undergoing combined exercise training. The exercise group showed improved glucose stability, with values maintained below the baseline [<xref rid="B65-nutrients-17-02860" ref-type="bibr">65</xref>].</p><p>Skeletal muscle plays a central role in glucose homeostasis, and its insulin resistance is the initial metabolic impairment in the development of T2D [<xref rid="B38-nutrients-17-02860" ref-type="bibr">38</xref>]. Both aerobic and resistance training independently improve metabolic outcomes [<xref rid="B52-nutrients-17-02860" ref-type="bibr">52</xref>,<xref rid="B53-nutrients-17-02860" ref-type="bibr">53</xref>,<xref rid="B54-nutrients-17-02860" ref-type="bibr">54</xref>,<xref rid="B55-nutrients-17-02860" ref-type="bibr">55</xref>,<xref rid="B56-nutrients-17-02860" ref-type="bibr">56</xref>,<xref rid="B57-nutrients-17-02860" ref-type="bibr">57</xref>,<xref rid="B58-nutrients-17-02860" ref-type="bibr">58</xref>,<xref rid="B59-nutrients-17-02860" ref-type="bibr">59</xref>,<xref rid="B60-nutrients-17-02860" ref-type="bibr">60</xref>,<xref rid="B61-nutrients-17-02860" ref-type="bibr">61</xref>,<xref rid="B62-nutrients-17-02860" ref-type="bibr">62</xref>]. However, combined exercise programs seem to offer the greatest benefit in terms of glycemic control, insulin sensitivity, and mitochondrial function [<xref rid="B63-nutrients-17-02860" ref-type="bibr">63</xref>,<xref rid="B64-nutrients-17-02860" ref-type="bibr">64</xref>,<xref rid="B65-nutrients-17-02860" ref-type="bibr">65</xref>]. These findings support the implementation of structured, multimodal physical activity as a cornerstone in the prevention and management of T2D.</p></sec></sec><sec id="sec4-nutrients-17-02860"><title>4. Creatine and Exercise&#8212;Synergistic Effects in the Prevention of Type 2 Diabetes</title><p>Physical activity plays a crucial role in the management of diabetes, alongside pharmacological treatment and diet. Regular exercise enhances insulin-independent glucose uptake in skeletal muscle, improves insulin sensitivity, and increases muscle glycogen stores [<xref rid="B22-nutrients-17-02860" ref-type="bibr">22</xref>,<xref rid="B66-nutrients-17-02860" ref-type="bibr">66</xref>,<xref rid="B67-nutrients-17-02860" ref-type="bibr">67</xref>,<xref rid="B68-nutrients-17-02860" ref-type="bibr">68</xref>,<xref rid="B69-nutrients-17-02860" ref-type="bibr">69</xref>,<xref rid="B70-nutrients-17-02860" ref-type="bibr">70</xref>,<xref rid="B71-nutrients-17-02860" ref-type="bibr">71</xref>,<xref rid="B72-nutrients-17-02860" ref-type="bibr">72</xref>,<xref rid="B73-nutrients-17-02860" ref-type="bibr">73</xref>].</p><p>Creatine is a widely used and common supplement among athletes and physically active individuals. It supports muscle mass, muscle strength, performance, and recovery [<xref rid="B74-nutrients-17-02860" ref-type="bibr">74</xref>,<xref rid="B75-nutrients-17-02860" ref-type="bibr">75</xref>,<xref rid="B76-nutrients-17-02860" ref-type="bibr">76</xref>,<xref rid="B77-nutrients-17-02860" ref-type="bibr">77</xref>,<xref rid="B78-nutrients-17-02860" ref-type="bibr">78</xref>,<xref rid="B79-nutrients-17-02860" ref-type="bibr">79</xref>]. Creatine increases PCr levels in muscles, which accelerates the regeneration of ATP, and this is the primary energy source during short, high-intensity efforts. This enhanced energy availability enables greater maximal strength and power output during exercise [<xref rid="B80-nutrients-17-02860" ref-type="bibr">80</xref>,<xref rid="B81-nutrients-17-02860" ref-type="bibr">81</xref>,<xref rid="B82-nutrients-17-02860" ref-type="bibr">82</xref>,<xref rid="B83-nutrients-17-02860" ref-type="bibr">83</xref>,<xref rid="B84-nutrients-17-02860" ref-type="bibr">84</xref>]. Additionally, creatine influences cellular hydration status, glycogen storage, calcium and protein metabolism, oxidative stress levels, inflammatory responses, stimulation of satellite cell activity, activation of myogenic regulatory factors, and the regulation of IGF-1 [<xref rid="B85-nutrients-17-02860" ref-type="bibr">85</xref>,<xref rid="B86-nutrients-17-02860" ref-type="bibr">86</xref>], which may contribute to the progressive enhancement of muscle tissue [<xref rid="B87-nutrients-17-02860" ref-type="bibr">87</xref>].</p><p>The combination of creatine supplementation with physical exercise can act synergistically in the prevention of T2D and sarcopenia through several mechanisms compared with each intervention used separately. One of these mechanisms is the increased glucose transport into muscle cells through the translocation of GLUT4 to the sarcolemma [<xref rid="B34-nutrients-17-02860" ref-type="bibr">34</xref>]. This transporter is sequestered intracellularly in the non-stimulated state. In response to insulin or muscle contraction, it translocates to the plasma membrane, resulting in glucose uptake and normalization of blood glucose levels (<xref rid="nutrients-17-02860-f002" ref-type="fig">Figure 2</xref>) [<xref rid="B88-nutrients-17-02860" ref-type="bibr">88</xref>,<xref rid="B89-nutrients-17-02860" ref-type="bibr">89</xref>].</p><sec><title>Clinical Evidence and Mechanistic Mediators</title><p>We identified randomized controlled trials combining creatine supplementation with exercise through a structured search of PubMed, using the keywords creatine, exercise, resistance training, T2D, and older adults. We included studies in adults with T2D, older adults, and experimental models relevant to these populations. Studies without a control group, without the combination of creatine and exercise, or conducted exclusively in animals/in vitro were excluded. In the following section, we discuss these studies, with their summary provided in <xref rid="nutrients-17-02860-t001" ref-type="table">Table 1</xref>.</p><p>Op&#8217;t Eijnde et al. conducted a double-blind, placebo-controlled trial with 22 healthy volunteers undergoing a two-week limb immobilization period. Participants were divided into two groups: one received creatine supplementation, while the other received a placebo. After immobilization, all participants underwent a 10-week rehabilitation program. The immobilization period caused a significant reduction in GLUT4 protein expression in the control group, whereas no such reduction occurred in the creatine group. Moreover, a significantly increased level of GLUT4 was observed in the creatine group during the rehabilitation phase. By the end of the 10-week recovery period, the creatine group exhibited approximately 40% higher GLUT4 expression compared with the placebo group. The researchers concluded that creatine supplementation helps prevent the reduction in muscle GLUT4 protein levels during immobilization and promotes an increase in GLUT4 content during rehabilitation training in healthy individuals [<xref rid="B23-nutrients-17-02860" ref-type="bibr">23</xref>]. Details of randomized and controlled trials combining creatine supplementation with exercise are presented in <xref rid="nutrients-17-02860-t001" ref-type="table">Table 1</xref>.</p><p>Similarly, Derave et al. examined the effects of creatine and creatine plus protein supplementation on GLUT4 and glycogen content of human skeletal muscle. The right legs of 33 healthy participants were immobilized for two weeks, followed by a six-week resistance training program for the right knee extensor muscles. Participants were supplemented throughout the study with either a placebo, creatine, or creatine during immobilization and creatine plus protein during retraining. The researchers concluded that creatine (especially when combined with protein) enhances GLUT4 recovery and upregulation and glycogen content, but only when paired with increased activity levels [<xref rid="B90-nutrients-17-02860" ref-type="bibr">90</xref>].</p><p>Gualano et al. evaluated the effects of creatine supplementation on glucose tolerance and insulin sensitivity in sedentary, healthy males undergoing aerobic training. In this randomized, double-blind, placebo-controlled trial, 22 volunteers received either creatine or a placebo while simultaneously participating in a moderate-intensity aerobic exercise program. The results demonstrated a significantly enhanced reduction in plasma glucose levels in response to the oral glucose tolerance test (OGTT) in the creatine group compared with the placebo group, but there were no differences in fasting insulin or homeostatic model assessment of insulin resistance (HOMA-IR).</p><p>In another trial, Oliveira et al. conducted a randomized, double-blind, placebo-controlled trial involving community-dwelling older adults. Participants were assigned to one of two groups: creatine supplementation combined with resistance training, or placebo combined with resistance training, and they completed a 12-week resistance training program. As with the previous study, improvements in fasting insulin and HOMA-IR were not observed, suggesting a potential additive effect of creatine on glycemic control, but not on insulin resistance [<xref rid="B92-nutrients-17-02860" ref-type="bibr">92</xref>].</p><p>The most compelling evidence comes from the study conducted by Gualano et al., which was a 12-week, randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of creatine supplementation combined with exercise on glycemic control in individuals with T2D. A total of 25 adults with diabetes were randomly assigned to receive either creatine monohydrate (CrM) or a placebo while undergoing an exercise program consisting of aerobic and resistance training sessions, performed three times per week. The researchers observed that creatine supplementation, along with exercise training, significantly reduced HbA1c and glycemia in response to a meal tolerance test. No significant differences were observed for insulin and C-peptide concentrations. This study suggests that the beneficial effect on glycemic control appears to be associated with enhanced GLUT4 translocation to the muscle cell membrane, rather than an increase in the overall GLUT4 protein content in muscle tissue. In the studies conducted by Newman et al. and Van Loon et al. [<xref rid="B95-nutrients-17-02860" ref-type="bibr">95</xref>,<xref rid="B96-nutrients-17-02860" ref-type="bibr">96</xref>], exercise was not included, which may explain the lack of observed effects of creatine.</p><p>The study by Alves et al. demonstrated that creatine may support the activity of AMPK, showing a positive relationship between changes in AMPK alpha levels and GLUT4 translocation. This may suggest that creatine supplementation could play a role in AMPK alpha signaling, potentially enhancing glucose transport into muscle cells and improving glycemic control in individuals with T2D [<xref rid="B93-nutrients-17-02860" ref-type="bibr">93</xref>]. Complementary evidence from exercise physiology indicates that physical activity, particularly at moderate to high intensity, also activates AMPK signaling in skeletal muscle [<xref rid="B97-nutrients-17-02860" ref-type="bibr">97</xref>,<xref rid="B98-nutrients-17-02860" ref-type="bibr">98</xref>]. Taken together, these findings suggest that both creatine supplementation and exercise may converge on the AMPK&#8211;GLUT4 pathway, potentially exerting additive benefits for glucose regulation in T2D.</p><p>In summary, creatine supplementation combined with physical exercise appears to enhance glucose uptake and glycemic control more effectively than either intervention alone, largely through GLUT4 translocation and possibly AMPK activation. Clinical trials indicate that this synergy is absent when creatine is used without exercise, underscoring the importance of combining both strategies in T2D management.</p></sec></sec><sec id="sec5-nutrients-17-02860"><title>5. Evidence-Based Safety Profile of Creatine Supplementation</title><sec id="sec5dot1-nutrients-17-02860"><title>5.1. Forms and Dosing Strategies</title><p>CrM remains the most extensively studied and widely recommended form of creatine supplementation due to its high purity, stability, and superior bioavailability (~99%) [<xref rid="B95-nutrients-17-02860" ref-type="bibr">95</xref>,<xref rid="B99-nutrients-17-02860" ref-type="bibr">99</xref>]. Compared with alternative forms such as creatine ethyl ester or buffered creatine, CrM consistently demonstrates greater muscle uptake and fewer degradation products [<xref rid="B99-nutrients-17-02860" ref-type="bibr">99</xref>]. Dosing strategies are typically structured around either a rapid &#8220;loading&#8221; phase or a more gradual &#8220;maintenance&#8221; approach. In many studies, the initial dosing consists of 20&#8211;25 g/day (0.3 g/kg/day), divided into four to five doses over 5&#8211;7 days [<xref rid="B100-nutrients-17-02860" ref-type="bibr">100</xref>,<xref rid="B101-nutrients-17-02860" ref-type="bibr">101</xref>]. This phase is followed by a maintenance dose of 3&#8211;5 g/day (or 0.03 g/kg/day) to sustain elevated intramuscular PCr stores. Notably, several studies have confirmed that daily ingestion of 3&#8211;5 g CrM without an initial loading phase can also achieve similar saturation levels over 3&#8211;4 weeks, offering a slower but equally effective alternative [<xref rid="B101-nutrients-17-02860" ref-type="bibr">101</xref>,<xref rid="B102-nutrients-17-02860" ref-type="bibr">102</xref>,<xref rid="B103-nutrients-17-02860" ref-type="bibr">103</xref>]. After cessation of supplementation, elevated creatine levels generally return toward baseline over ~4&#8211;6 weeks [<xref rid="B103-nutrients-17-02860" ref-type="bibr">103</xref>].</p><p>Emerging evidence supports flexible dosing strategies across demographics, including elderly individuals. For older adults, chronic intake of 0.1 g/kg/day has been shown to enhance muscle function without impairing renal or hepatic markers, underscoring CrM&#8217;s favorable safety profile across clinical contexts [<xref rid="B104-nutrients-17-02860" ref-type="bibr">104</xref>,<xref rid="B105-nutrients-17-02860" ref-type="bibr">105</xref>,<xref rid="B106-nutrients-17-02860" ref-type="bibr">106</xref>,<xref rid="B107-nutrients-17-02860" ref-type="bibr">107</xref>,<xref rid="B108-nutrients-17-02860" ref-type="bibr">108</xref>,<xref rid="B109-nutrients-17-02860" ref-type="bibr">109</xref>,<xref rid="B110-nutrients-17-02860" ref-type="bibr">110</xref>,<xref rid="B111-nutrients-17-02860" ref-type="bibr">111</xref>]. Moreover, dietary creatine intake (1&#8211;3 g/day) remains suboptimal in vegetarians and elderly individuals, further justifying targeted CrM supplementation in these groups [<xref rid="B106-nutrients-17-02860" ref-type="bibr">106</xref>,<xref rid="B107-nutrients-17-02860" ref-type="bibr">107</xref>].</p></sec><sec id="sec5dot2-nutrients-17-02860"><title>5.2. Safety Profile and Adverse Effects of Creatine Supplementation in Healthy and Clinical Populations</title><p>The safety profile of CrM has been extensively evaluated across age groups and health statuses, with no clinically significant adverse effects reported when used within recommended dosages. According to the International Society of Sports Nutrition (ISSN), creatine is among the most studied and well-tolerated supplements in both exercise and clinical nutrition, supported by over a thousand peer-reviewed publications [<xref rid="B84-nutrients-17-02860" ref-type="bibr">84</xref>]. Aside from transient weight gain due to increased intracellular water retention, controlled studies have found no consistent or causally substantiated adverse events such as musculoskeletal injury, dehydration, gastrointestinal discomfort, or muscle cramping [<xref rid="B84-nutrients-17-02860" ref-type="bibr">84</xref>,<xref rid="B108-nutrients-17-02860" ref-type="bibr">108</xref>].</p><p>Despite persistent public concern regarding CrM as a potentially nephrotoxic or hepatotoxic agent, current evidence overwhelmingly indicates that such fears are largely unfounded in both healthy and clinical populations [<xref rid="B84-nutrients-17-02860" ref-type="bibr">84</xref>,<xref rid="B110-nutrients-17-02860" ref-type="bibr">110</xref>,<xref rid="B112-nutrients-17-02860" ref-type="bibr">112</xref>,<xref rid="B113-nutrients-17-02860" ref-type="bibr">113</xref>]. Early case reports associating CrM with elevated serum creatinine or impaired kidney function often lacked control for confounding variables such as co-ingested supplements or pre-existing renal conditions [<xref rid="B114-nutrients-17-02860" ref-type="bibr">114</xref>,<xref rid="B115-nutrients-17-02860" ref-type="bibr">115</xref>]. A seminal long-term observational study by Poortmans et al. followed elite athletes, who self-administered oral creatine (reported in some cases up to 80 g/day) over 10 months to 5 years. No statistically significant differences in plasma creatinine, urea, or albumin levels were observed between creatine users and matched controls, nor were alterations in glomerular filtration rate, tubular reabsorption, or membrane permeability detected; however, randomized trials are needed to confirm long-term safety at high intake levels [<xref rid="B116-nutrients-17-02860" ref-type="bibr">116</xref>].</p><p>These results were corroborated by randomized controlled trials involving patients with neurodegenerative disorders, which consistently reported no CrM-induced renal or hepatic dysfunction [<xref rid="B117-nutrients-17-02860" ref-type="bibr">117</xref>]. Notably, the transient elevation in serum creatinine sometimes observed following supplementation is now understood as a benign consequence of creatine&#8217;s spontaneous conversion to creatinine, rather than impaired filtration [<xref rid="B118-nutrients-17-02860" ref-type="bibr">118</xref>]. Supporting this, a Mendelian randomization analysis of 1229 participants found no association between systemic creatine levels and six key markers of renal function, reinforcing the notion that excess creatine is efficiently cleared without causing glomerular damage [<xref rid="B119-nutrients-17-02860" ref-type="bibr">119</xref>]. While some dose-dependent increases in serum or urinary creatinine have been noted, particularly in older adults, these values remained within physiological norms and likely reflect elevated muscle turnover rather than organ dysfunction [<xref rid="B120-nutrients-17-02860" ref-type="bibr">120</xref>,<xref rid="B121-nutrients-17-02860" ref-type="bibr">121</xref>].</p><p>Further support for creatine&#8217;s renal safety comes from animal studies. Ferreira et al. and Baracho et al. demonstrated that even supraphysiological doses of creatine (up to 2 g/kg/day) in Wistar rats did not impair glomerular filtration, renal plasma flow, or liver integrity [<xref rid="B109-nutrients-17-02860" ref-type="bibr">109</xref>,<xref rid="B110-nutrients-17-02860" ref-type="bibr">110</xref>]. Similarly, clinical trials involving human participants consuming up to 30 g/day of creatine for as long as five years reported no meaningful changes in renal or hepatic markers [<xref rid="B111-nutrients-17-02860" ref-type="bibr">111</xref>,<xref rid="B112-nutrients-17-02860" ref-type="bibr">112</xref>,<xref rid="B116-nutrients-17-02860" ref-type="bibr">116</xref>].</p><p>Reinforcing this body of evidence, a comprehensive systematic review and meta-analysis of 685 randomized human trials concluded that CrM supplementation does not increase adverse event incidence compared to placebo. Across over 26,000 participants, adverse effects were reported by 4.60% of creatine users versus 4.21% in the placebo group, a non-significant difference (<italic toggle="yes">p</italic> = 0.828). No elevated rates of gastrointestinal symptoms (<italic toggle="yes">p</italic> = 0.820), muscle cramping (<italic toggle="yes">p</italic> = 0.085), or renal abnormalities were observed. These findings were consistent across children, older adults, clinical patients, and athletes, confirming CrM&#8217;s broad tolerability across diverse physiological conditions. Importantly, even high-dose and long-duration protocols did not alter safety outcomes, affirming CrM&#8217;s role in evidence-based nutritional strategies [<xref rid="B122-nutrients-17-02860" ref-type="bibr">122</xref>].</p></sec><sec id="sec5dot3-nutrients-17-02860"><title>5.3. Safety and Metabolic Tolerability of Creatine Monohydrate in Older Adults with T2D and Sarcopenia</title><p>Emerging evidence suggests that CrM supplementation is safe for use in older individuals with T2D, a group often affected by sarcopenia and multimorbidity. Gualano et al. demonstrated that 12 weeks of creatine intake at a dosage of 5 g/day in patients with T2D did not adversely affect renal function, as measured by albuminuria, proteinuria, blood urea nitrogen, and estimated creatinine clearance, indicating preserved kidney integrity under supplementation [<xref rid="B123-nutrients-17-02860" ref-type="bibr">123</xref>].</p><p>In a cohort of frail older adults (n = 9; 70 &#177; 5 years), Collins et al. reported that combining 5 g/day of CrM with protein intake during 14 weeks of resistance training did not affect serum levels of renal or hepatic markers, including blood urea nitrogen, creatinine, bilirubin, alkaline phosphatase, gamma-glutamyltransferase, alanine aminotransferase, aspartate aminotransferase, or creatine kinase, suggesting no detectable organ toxicity in this population [<xref rid="B94-nutrients-17-02860" ref-type="bibr">94</xref>].</p><p>Similarly, long-term studies in postmenopausal women receiving creatine at either 1 g/day or 0.1 g/kg/day for 12 months revealed no detrimental changes in markers of liver or kidney function, including urinary microalbumin, urine protein, and glomerular filtration indicators [<xref rid="B124-nutrients-17-02860" ref-type="bibr">124</xref>]. Additionally, no signs of cytotoxicity were observed, as evidenced by unchanged urinary formaldehyde levels in elderly men undergoing whole-body resistance training for 10 weeks while receiving CrM (0.1 g/kg/day) [<xref rid="B105-nutrients-17-02860" ref-type="bibr">105</xref>].</p><p>Building on emerging evidence of creatine&#8217;s favorable safety profile in clinical populations, a systematic review by de Sousa et al. critically assessed the efficacy and tolerability of CrM in individuals with T2D. The review synthesized findings from three randomized controlled trials involving 87 participants, in which CrM was compared to placebo, metformin, and glibenclamide. Across studies, CrM supplementation led to modest yet favorable reductions in fasting blood glucose and HbA1c, without exceeding the glycemic efficacy of conventional pharmacotherapies. Importantly, none of the trials reported any serious adverse events attributable to CrM, reinforcing its metabolic safety in this high-risk population. However, due to small sample sizes and heterogeneity in study design, the authors urged caution in interpretation and highlighted the need for large-scale, long-term trials [<xref rid="B125-nutrients-17-02860" ref-type="bibr">125</xref>].</p></sec><sec id="sec5dot4-nutrients-17-02860"><title>5.4. Creatine Co-Supplementation: Pharmacokinetic Interactions and Clinical Implications</title><p>The safety and efficacy of CrM are well-established; however, its concurrent administration with other dietary components or pharmaceutical agents introduces pharmacokinetic and pharmacodynamic complexities that merit critical evaluation in both athletic and clinical settings. Caffeine remains one of the most frequently co-consumed compounds with creatine, and its interaction profile is paradoxical. A systematic review by Elosegui et al. demonstrated that acute co-administration of caffeine and creatine does not impair caffeine&#8217;s ergogenic effects, yet chronic simultaneous supplementation may attenuate creatine&#8217;s performance-enhancing properties, possibly via antagonistic effects on muscle relaxation dynamics and calcium handling [<xref rid="B126-nutrients-17-02860" ref-type="bibr">126</xref>]. Trexler et al. further support this hypothesis, indicating that ergogenic blunting occurs without changes in creatine&#8217;s plasma kinetics, suggesting a non-systemic mechanism [<xref rid="B127-nutrients-17-02860" ref-type="bibr">127</xref>]. Vanakoski et al. also found no significant changes in maximum plasma concentration (Cmax), time to reach maximum plasma concentration (Tmax), or half-life of creatine when co-ingested with caffeine, reinforcing the likelihood of local (muscle-level) rather than systemic interactions [<xref rid="B128-nutrients-17-02860" ref-type="bibr">128</xref>].</p><p>Carbohydrate co-ingestion, on the other hand, has been shown to significantly enhance creatine uptake via insulin-mediated pathways. Green et al. and Steenge et al. demonstrated that combining CrM with simple sugars reduced plasma creatine area under the curve (AUC) and urinary excretion, while increasing intramuscular retention&#8212;effects attributed to insulin&#8217;s role in upregulating muscle creatine transporter activity. These observations confirm that co-ingestion with carbohydrates enhances bioavailability and muscular deposition of creatine through endocrine mechanisms. This has clinical relevance in populations with altered insulin sensitivity, such as individuals with metabolic syndrome or T2D [<xref rid="B129-nutrients-17-02860" ref-type="bibr">129</xref>,<xref rid="B130-nutrients-17-02860" ref-type="bibr">130</xref>].</p><p>The form of creatine ingested may also influence efficacy; for example, creatine ethyl ester&#8212;despite claims of improved bioavailability via reduced hydrophilicity and transporter-independent uptake&#8212;undergoes rapid nonenzymatic conversion to creatinine and does not meaningfully increase intramuscular PCr stores [<xref rid="B102-nutrients-17-02860" ref-type="bibr">102</xref>].</p><p>Beyond nutrient&#8211;nutrient interactions, emerging data point to possible drug&#8211;creatine interactions that could have important clinical implications. According to the drug&#8211;drug interaction database (DDInter), CrM has the potential to interact with several pharmaceutical agents, including pemetrexed, entecavir, cimetidine, trimethoprim, and probenecid. Co-administration of CrM with these compounds, particularly in older adults, may elevate both serum drug concentrations and serum creatinine levels, raising important concerns about altered renal clearance and potential misinterpretation of kidney function biomarkers in polypharmacy contexts [<xref rid="B107-nutrients-17-02860" ref-type="bibr">107</xref>]. These signals require clinical verification; monitor renal function and consider drug pharmacokinetics in polypharmacy, especially in older adults.</p><p>In summary, CrM remains a safe and effective supplement when used in isolation, but co-administration with other agents, such as caffeine or specific pharmaceutical drugs, may modulate its efficacy or confound biomarker interpretation. Future studies should aim to standardize co-supplementation protocols and evaluate population-specific pharmacodynamic responses, especially in older adults and those with comorbidities or complex medication regimens.</p></sec></sec><sec sec-type="conclusions" id="sec6-nutrients-17-02860"><title>6. Conclusions</title><p>Current evidence from mechanistic studies and clinical trials indicates that creatine supplementation, principally as creatine monohydrate, combined with structured resistance and/or aerobic exercise, is a promising adjunct for the prevention and management of T2D. The combined intervention consistently improves muscle glucose handling via enhanced GLUT4 translocation, greater muscle glycogen storage, and possible AMPK modulation and augments muscle mass and strength. These effects plausibly translate into improved glycemic control and mitigation of sarcopenia-related metabolic decline. Importantly, benefits reported to date are most robust when creatine is administered together with exercise; creatine alone yields smaller and less consistent glycemic effects.</p><p>The safety profile of creatine at commonly recommended regimens (for example, 3&#8211;5 g/day or standard short loading protocols) appears favorable, including in older adults and persons with T2D. Randomized and observational data do not support clinically meaningful nephrotoxicity or hepatotoxicity in otherwise stable populations. Long-term evidence for very high chronic dosing (e.g., sustained &gt; 20&#8211;30 g/day) is limited, and such regimens should be approached cautiously. A clinically relevant issue is the dual interpretation of creatinine: it is both the metabolic breakdown product influenced by supplementation and a marker of muscle mass. Modest rises in serum creatinine after creatine intake commonly reflect increased creatine&#8211;creatinine conversion or greater muscle mass/turnover rather than true renal injury. Conversely, low creatinine may signal reduced muscle mass and sarcopenia. To avoid misclassification, combine biochemical monitoring with direct measures of muscle mass and function (e.g., DXA or bioimpedance, handgrip strength, physical performance tests) and consider creatinine-independent renal markers (e.g., cystatin C) when clinically appropriate. Pharmacokinetic and pharmacodynamic interactions (signals reported with certain drugs, caffeine, or co-ingested nutrients) warrant clinician awareness but require further clinical verification. In patients with polypharmacy or pre-existing kidney disease, perform baseline renal assessment, monitor function periodically, and interpret creatinine-based GFR estimates with caution.</p><p>Research priorities remain: adequately powered, long-term randomized controlled trials in people with T2D, particularly older adults and those with sarcopenia, are needed to define optimal dosing and duration, confirm durability of metabolic and functional benefits, and establish safety in multimorbid and polypharmacy contexts. Trials should include mechanistic endpoints (GLUT4, AMPK, muscle glycogen, satellite cell activity), standardized co-supplementation protocols, and creatinine-independent renal assessment where feasible.</p><p>Overall, the reviewed evidence supports the considered use of creatine supplementation combined with exercise as a safe and potentially effective adjunct to standard T2D prevention and management strategies, provided that interventions are individualized and appropriate monitoring is implemented.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><glossary><title>Abbreviations</title><p>The following abbreviations are used in this manuscript:
<array orientation="portrait"><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">T2D</td><td align="left" valign="middle" rowspan="1" colspan="1">Type 2 Diabetes</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IDF</td><td align="left" valign="middle" rowspan="1" colspan="1">International Diabetes Federation</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HbA1c</td><td align="left" valign="middle" rowspan="1" colspan="1">Glycated Hemoglobin</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PCr</td><td align="left" valign="middle" rowspan="1" colspan="1">Phosphocreatine</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CK</td><td align="left" valign="middle" rowspan="1" colspan="1">Creatine Kinase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CRTR</td><td align="left" valign="middle" rowspan="1" colspan="1">Creatine Transporter </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ROS</td><td align="left" valign="middle" rowspan="1" colspan="1">Reactive Oxygen Species</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AMPK</td><td align="left" valign="middle" rowspan="1" colspan="1">AMP-Activated Protein Kinase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PGC-1&#945;</td><td align="left" valign="middle" rowspan="1" colspan="1">Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-Alpha</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NF-&#954;B</td><td align="left" valign="middle" rowspan="1" colspan="1">Nuclear Factor Kappa B</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">p38 MAPK</td><td align="left" valign="middle" rowspan="1" colspan="1">P38 Mitogen-Activated Protein Kinase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TNF-&#945; </td><td align="left" valign="middle" rowspan="1" colspan="1">Tumor Necrosis Factor Alpha</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IL-1&#946; </td><td align="left" valign="middle" rowspan="1" colspan="1">Interleukin-1 Beta</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">STAT1/3</td><td align="left" valign="middle" rowspan="1" colspan="1">Signal Transducer And Activator Of Transcription 1/3</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IGF-1</td><td align="left" valign="middle" rowspan="1" colspan="1">Insulin-Like Growth Factor 1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GH</td><td align="left" valign="middle" rowspan="1" colspan="1">Growth Hormone</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">mTORC1</td><td align="left" valign="middle" rowspan="1" colspan="1">Mechanistic Target Of Rapamycin Complex 1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GLUT4</td><td align="left" valign="middle" rowspan="1" colspan="1">Glucose Transporter Type 4</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Akt/PKB</td><td align="left" valign="middle" rowspan="1" colspan="1">Protein Kinase B</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Rac1</td><td align="left" valign="middle" rowspan="1" colspan="1">Ras-Related C3 Botulinum Toxin Substrate 1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CaMK</td><td align="left" valign="middle" rowspan="1" colspan="1">Calcium/Calmodulin-Dependent Protein Kinase</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IRS </td><td align="left" valign="middle" rowspan="1" colspan="1">Insulin Receptor Substrate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">WHO</td><td align="left" valign="middle" rowspan="1" colspan="1">World Health Organization</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">OGTT</td><td align="left" valign="middle" rowspan="1" colspan="1">Oral Glucose Tolerance Test</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HOMA-IR </td><td align="left" valign="middle" rowspan="1" colspan="1">Homeostatic Model Assessment Of Insulin Resistance</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CrM</td><td align="left" valign="middle" rowspan="1" colspan="1">Creatine Monohydrate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ISSN</td><td align="left" valign="middle" rowspan="1" colspan="1">International Society Of Sports Nutrition</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cmax</td><td align="left" valign="middle" rowspan="1" colspan="1">Maximum Plasma Concentration</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Tmax</td><td align="left" valign="middle" rowspan="1" colspan="1">Time To Reach Maximum Plasma Concentration</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AUC</td><td align="left" valign="middle" rowspan="1" colspan="1">Area Under The Curve</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CEE</td><td align="left" valign="middle" rowspan="1" colspan="1">Creatine Ethyl Ester</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DDInter</td><td align="left" valign="middle" rowspan="1" colspan="1">Drug&#8211;Drug Interaction Database</td></tr></tbody></array></p></glossary><ref-list><title>References</title><ref id="B1-nutrients-17-02860"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>M&#322;ynarska</surname><given-names>E.</given-names></name><name name-style="western"><surname>Czarnik</surname><given-names>W.</given-names></name><name name-style="western"><surname>Dzie&#380;a</surname><given-names>N.</given-names></name><name name-style="western"><surname>J&#281;draszak</surname><given-names>W.</given-names></name><name name-style="western"><surname>Majchrowicz</surname><given-names>G.</given-names></name><name name-style="western"><surname>Prusinowski</surname><given-names>F.</given-names></name><name name-style="western"><surname>Stabrawa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rysz</surname><given-names>J.</given-names></name><name name-style="western"><surname>Franczyk</surname><given-names>B.</given-names></name></person-group><article-title>Type 2 diabetes mellitus: New pathogenetic mechanisms, treatment and the most important complications</article-title><source>Int. J. Mol. Sci.</source><year>2025</year><volume>26</volume><elocation-id>1094</elocation-id><pub-id pub-id-type="doi">10.3390/ijms26031094</pub-id><pub-id pub-id-type="pmid">39940862</pub-id><pub-id pub-id-type="pmcid">PMC11817707</pub-id></element-citation></ref><ref id="B2-nutrients-17-02860"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Goyal</surname><given-names>R.</given-names></name><name name-style="western"><surname>Singhal</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jialal</surname><given-names>I.</given-names></name></person-group><article-title>Type 2 diabetes</article-title><source>StatPearls</source><publisher-name>StatPearls Publishing</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2025</year><pub-id pub-id-type="pmid">30020625</pub-id></element-citation></ref><ref id="B3-nutrients-17-02860"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chi</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Setrerrahmane</surname><given-names>S.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>W.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>H.</given-names></name></person-group><article-title>Trends in insulin resistance: Insights into mechanisms and therapeutic strategy</article-title><source>Signal Transduct. Target. Ther.</source><year>2022</year><volume>7</volume><fpage>216</fpage><pub-id pub-id-type="doi">10.1038/s41392-022-01073-0</pub-id><pub-id pub-id-type="pmid">35794109</pub-id><pub-id pub-id-type="pmcid">PMC9259665</pub-id></element-citation></ref><ref id="B4-nutrients-17-02860"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Long</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Ning</surname><given-names>H.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>A.</given-names></name></person-group><article-title>Global burden of type 2 diabetes in adolescents and young adults, 1990-2019: Systematic analysis of the Global Burden of Disease Study 2019</article-title><source>BMJ</source><year>2022</year><volume>379</volume><fpage>e072385</fpage><pub-id pub-id-type="doi">10.1136/bmj-2022-072385</pub-id><pub-id pub-id-type="pmid">36740855</pub-id><pub-id pub-id-type="pmcid">PMC9727920</pub-id></element-citation></ref><ref id="B5-nutrients-17-02860"><label>5.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>International Diabetes Federation</collab></person-group><source>IDF Diabetes Atlas</source><edition>11th ed.</edition><publisher-name>International Diabetes Federation</publisher-name><publisher-loc>Brussels, Belgium</publisher-loc><year>2025</year></element-citation></ref><ref id="B6-nutrients-17-02860"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>H.</given-names></name><name name-style="western"><surname>Saeedi</surname><given-names>P.</given-names></name><name name-style="western"><surname>Karuranga</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pinkepank</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ogurtsova</surname><given-names>K.</given-names></name><name name-style="western"><surname>Duncan</surname><given-names>B.B.</given-names></name><name name-style="western"><surname>Stein</surname><given-names>C.</given-names></name><name name-style="western"><surname>Basit</surname><given-names>A.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Mbanya</surname><given-names>J.C.</given-names></name><etal/></person-group><article-title>IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045</article-title><source>Diabetes Res. Clin. Pract.</source><year>2022</year><volume>183</volume><fpage>109119</fpage><pub-id pub-id-type="doi">10.1016/j.diabres.2021.109119</pub-id><pub-id pub-id-type="pmid">34879977</pub-id><pub-id pub-id-type="pmcid">PMC11057359</pub-id></element-citation></ref><ref id="B7-nutrients-17-02860"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>B.</given-names></name><name name-style="western"><surname>Rayner</surname><given-names>A.W.</given-names></name><name name-style="western"><surname>Gregg</surname><given-names>E.W.</given-names></name><name name-style="western"><surname>E Sheffer</surname><given-names>K.</given-names></name><name name-style="western"><surname>Carrillo-Larco</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>E Bennett</surname><given-names>J.</given-names></name><name name-style="western"><surname>E Shaw</surname><given-names>J.</given-names></name><name name-style="western"><surname>Paciorek</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Singleton</surname><given-names>R.K.</given-names></name><name name-style="western"><surname>Pires</surname><given-names>A.B.</given-names></name><etal/></person-group><article-title>Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: A pooled analysis of 1108 population-representative studies with 141 million participants</article-title><source>Lancet</source><year>2024</year><volume>404</volume><fpage>2077</fpage><lpage>2093</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(24)02317-1</pub-id><pub-id pub-id-type="pmid">39549716</pub-id><pub-id pub-id-type="pmcid">PMC7616842</pub-id></element-citation></ref><ref id="B8-nutrients-17-02860"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenberg</surname><given-names>I.H.</given-names></name></person-group><article-title>Sarcopenia: Origins and clinical relevance</article-title><source>J. Nutr.</source><year>1997</year><volume>127</volume><issue>(Suppl. S5)</issue><fpage>990S</fpage><lpage>991S</lpage><pub-id pub-id-type="doi">10.1093/jn/127.5.990S</pub-id><pub-id pub-id-type="pmid">9164280</pub-id></element-citation></ref><ref id="B9-nutrients-17-02860"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>S.W.</given-names></name><name name-style="western"><surname>Youm</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>W.</given-names></name><name name-style="western"><surname>Chu</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Park</surname><given-names>Y.-R.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H.C.</given-names></name></person-group><article-title>Appendicular skeletal muscle mass and insulin resistance in an elderly korean population: The korean social life, health and aging project-health examination cohort</article-title><source>Diabetes Metab. J.</source><year>2015</year><volume>39</volume><fpage>37</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.4093/dmj.2015.39.1.37</pub-id><pub-id pub-id-type="pmid">25729711</pub-id><pub-id pub-id-type="pmcid">PMC4342535</pub-id></element-citation></ref><ref id="B10-nutrients-17-02860"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>M.</given-names></name></person-group><article-title>Association between metabolic score for insulin resistance and prevalence of sarcopenia in US adults: A study based on NHANES 2011 to 2018</article-title><source>Medicine</source><year>2025</year><volume>104</volume><fpage>e41863</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000041863</pub-id><pub-id pub-id-type="pmid">40101023</pub-id><pub-id pub-id-type="pmcid">PMC11922397</pub-id></element-citation></ref><ref id="B11-nutrients-17-02860"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Du</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mitch</surname><given-names>W.E.</given-names></name></person-group><article-title>Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling</article-title><source>Endocrinology</source><year>2006</year><volume>147</volume><fpage>4160</fpage><lpage>4168</lpage><pub-id pub-id-type="doi">10.1210/en.2006-0251</pub-id><pub-id pub-id-type="pmid">16777975</pub-id></element-citation></ref><ref id="B12-nutrients-17-02860"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H.J.</given-names></name></person-group><article-title>Insulin sensitivity and muscle loss in the absence of diabetes mellitus: Findings from a longitudinal community-based cohort study</article-title><source>J. Clin. Med.</source><year>2025</year><volume>14</volume><elocation-id>1270</elocation-id><pub-id pub-id-type="doi">10.3390/jcm14041270</pub-id><pub-id pub-id-type="pmid">40004800</pub-id><pub-id pub-id-type="pmcid">PMC11856990</pub-id></element-citation></ref><ref id="B13-nutrients-17-02860"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Srikanthan</surname><given-names>P.</given-names></name><name name-style="western"><surname>Hevener</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Karlamangla</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Earnest</surname><given-names>C.P.</given-names></name></person-group><article-title>Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: Findings from the National Health and Nutrition Examination Survey III</article-title><source>PLoS ONE</source><year>2010</year><volume>5</volume><elocation-id>e10805</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0010805</pub-id><pub-id pub-id-type="pmid">22421977</pub-id><pub-id pub-id-type="pmcid">PMC3279294</pub-id></element-citation></ref><ref id="B14-nutrients-17-02860"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Du</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>X.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>T.</given-names></name></person-group><article-title>Analysis of risk factors for the association of sarcopenia in patients with type 2 diabetes mellitus</article-title><source>Diabetes Metab. Syndr. Obes. Targets Ther.</source><year>2024</year><volume>17</volume><fpage>1455</fpage><lpage>1466</lpage><pub-id pub-id-type="doi">10.2147/DMSO.S446894</pub-id><pub-id pub-id-type="pmcid">PMC10982580</pub-id><pub-id pub-id-type="pmid">38562278</pub-id></element-citation></ref><ref id="B15-nutrients-17-02860"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dai</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Meng</surname><given-names>F.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>W.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>F.</given-names></name></person-group><article-title>Higher risk of sarcopenia in older adults with type 2 diabetes: NHANES 1999&#8211;2018</article-title><source>Obes. Facts</source><year>2023</year><volume>16</volume><fpage>237</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1159/000530241</pub-id><pub-id pub-id-type="pmid">37011596</pub-id><pub-id pub-id-type="pmcid">PMC10826600</pub-id></element-citation></ref><ref id="B16-nutrients-17-02860"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mesinovic</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zengin</surname><given-names>A.</given-names></name><name name-style="western"><surname>De Courten</surname><given-names>B.</given-names></name><name name-style="western"><surname>Ebeling</surname><given-names>P.R.</given-names></name><name name-style="western"><surname>Scott</surname><given-names>D.</given-names></name></person-group><article-title>Sarcopenia and type 2 diabetes mellitus: A bidirectional relationship</article-title><source>Diabetes Metab. Syndr. Obes. Targets Ther.</source><year>2019</year><volume>12</volume><fpage>1057</fpage><lpage>1072</lpage><pub-id pub-id-type="doi">10.2147/DMSO.S186600</pub-id><pub-id pub-id-type="pmid">31372016</pub-id><pub-id pub-id-type="pmcid">PMC6630094</pub-id></element-citation></ref><ref id="B17-nutrients-17-02860"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshimura</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Matsumoto</surname><given-names>A.</given-names></name><name name-style="western"><surname>Inoue</surname><given-names>T.</given-names></name><name name-style="western"><surname>Okamura</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kuzuya</surname><given-names>M.</given-names></name></person-group><article-title>Protein supplementation alone or combined with exercise for sarcopenia and physical frailty: A systematic review and meta-analysis of randomized controlled trials</article-title><source>Arch. Gerontol. Geriatr.</source><year>2025</year><volume>131</volume><fpage>105783</fpage><pub-id pub-id-type="doi">10.1016/j.archger.2025.105783</pub-id><pub-id pub-id-type="pmid">39955964</pub-id></element-citation></ref><ref id="B18-nutrients-17-02860"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wrench</surname><given-names>E.</given-names></name><name name-style="western"><surname>Rattley</surname><given-names>K.</given-names></name><name name-style="western"><surname>Lambert</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Killick</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hayes</surname><given-names>L.D.</given-names></name><name name-style="western"><surname>Lauder</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Gaffney</surname><given-names>C.J.</given-names></name></person-group><article-title>There is no dose&#8211;response relationship between the amount of exercise and improvement in HbA1c in interventions over 12 weeks in patients with type 2 diabetes: A meta-analysis and meta-regression</article-title><source>Acta Diabetol.</source><year>2022</year><volume>59</volume><fpage>1399</fpage><lpage>1415</lpage><pub-id pub-id-type="doi">10.1007/s00592-022-01918-8</pub-id><pub-id pub-id-type="pmid">35930075</pub-id><pub-id pub-id-type="pmcid">PMC9519659</pub-id></element-citation></ref><ref id="B19-nutrients-17-02860"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bweir</surname><given-names>S.</given-names></name><name name-style="western"><surname>Al-Jarrah</surname><given-names>M.</given-names></name><name name-style="western"><surname>Almalty</surname><given-names>A.-M.</given-names></name><name name-style="western"><surname>Maayah</surname><given-names>M.</given-names></name><name name-style="western"><surname>Smirnova</surname><given-names>I.V.</given-names></name><name name-style="western"><surname>Novikova</surname><given-names>L.</given-names></name><name name-style="western"><surname>Stehno-Bittel</surname><given-names>L.</given-names></name></person-group><article-title>Resistance exercise training lowers HbA1c more than aerobic training in adults with type 2 diabetes</article-title><source>Diabetol. Metab. Syndr.</source><year>2009</year><volume>1</volume><fpage>27</fpage><pub-id pub-id-type="doi">10.1186/1758-5996-1-27</pub-id><pub-id pub-id-type="pmid">20003276</pub-id><pub-id pub-id-type="pmcid">PMC2800839</pub-id></element-citation></ref><ref id="B20-nutrients-17-02860"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LaBotz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>B.W.</given-names></name></person-group><article-title>Creatine supplement use in an NCAA Division I athletic program</article-title><source>Clin. J. Sport Med.</source><year>1999</year><volume>9</volume><fpage>167</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1097/00042752-199907000-00009</pub-id><pub-id pub-id-type="pmid">10512346</pub-id></element-citation></ref><ref id="B21-nutrients-17-02860"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hall</surname><given-names>M.</given-names></name><name name-style="western"><surname>Manetta</surname><given-names>E.</given-names></name><name name-style="western"><surname>Tupper</surname><given-names>K.</given-names></name></person-group><article-title>Creatine supplementation: An update</article-title><source>Curr. Sports Med. Rep.</source><year>2021</year><volume>20</volume><fpage>338</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1249/JSR.0000000000000863</pub-id><pub-id pub-id-type="pmid">34234088</pub-id></element-citation></ref><ref id="B22-nutrients-17-02860"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gualano</surname><given-names>B.</given-names></name><name name-style="western"><surname>Painneli</surname><given-names>V.D.S.</given-names></name><name name-style="western"><surname>Roschel</surname><given-names>H.</given-names></name><name name-style="western"><surname>Artioli</surname><given-names>G.G.</given-names></name><name name-style="western"><surname>Neves</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pinto</surname><given-names>A.L.D.S.</given-names></name><name name-style="western"><surname>DA Silva</surname><given-names>M.E.R.</given-names></name><name name-style="western"><surname>Cunha</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Otaduy</surname><given-names>M.C.G.</given-names></name><name name-style="western"><surname>Leite</surname><given-names>C.D.C.</given-names></name><etal/></person-group><article-title>Creatine in type 2 diabetes: A randomized, double-blind, placebo-controlled trial</article-title><source>Med. Sci. Sports Exerc.</source><year>2011</year><volume>43</volume><fpage>770</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e3181fcee7d</pub-id><pub-id pub-id-type="pmid">20881878</pub-id></element-citation></ref><ref id="B23-nutrients-17-02860"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eijnde</surname><given-names>B.O.</given-names></name><name name-style="western"><surname>Urs&#248;</surname><given-names>B.</given-names></name><name name-style="western"><surname>Richter</surname><given-names>E.</given-names></name><name name-style="western"><surname>Greenhaff</surname><given-names>P.</given-names></name><name name-style="western"><surname>Hespel</surname><given-names>P.</given-names></name></person-group><article-title>Effect of oral creatine supplementation on human muscle glut4 protein content after immobilization</article-title><source>Diabetes</source><year>2001</year><volume>50</volume><fpage>18</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.2337/diabetes.50.1.18</pub-id><pub-id pub-id-type="pmid">11147785</pub-id></element-citation></ref><ref id="B24-nutrients-17-02860"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mills</surname><given-names>S.</given-names></name><name name-style="western"><surname>Candow</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Forbes</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Neary</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Ormsbee</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Antonio</surname><given-names>J.</given-names></name></person-group><article-title>Effects of creatine supplementation during resistance training sessions in physically active young adults</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><elocation-id>1880</elocation-id><pub-id pub-id-type="doi">10.3390/nu12061880</pub-id><pub-id pub-id-type="pmid">32599716</pub-id><pub-id pub-id-type="pmcid">PMC7353308</pub-id></element-citation></ref><ref id="B25-nutrients-17-02860"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johannsmeyer</surname><given-names>S.</given-names></name><name name-style="western"><surname>Candow</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Brahms</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Michel</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zello</surname><given-names>G.A.</given-names></name></person-group><article-title>Effect of creatine supplementation and drop-set resistance training in untrained aging adults</article-title><source>Exp. Gerontol.</source><year>2016</year><volume>83</volume><fpage>112</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.exger.2016.08.005</pub-id><pub-id pub-id-type="pmid">27523919</pub-id></element-citation></ref><ref id="B26-nutrients-17-02860"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kreider</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Stout</surname><given-names>J.R.</given-names></name></person-group><article-title>Creatine in health and disease</article-title><source>Nutrients</source><year>2021</year><volume>13</volume><elocation-id>447</elocation-id><pub-id pub-id-type="doi">10.3390/nu13020447</pub-id><pub-id pub-id-type="pmid">33572884</pub-id><pub-id pub-id-type="pmcid">PMC7910963</pub-id></element-citation></ref><ref id="B27-nutrients-17-02860"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Terjung</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Clarkson</surname><given-names>P.</given-names></name><name name-style="western"><surname>Eichner</surname><given-names>E.R.</given-names></name><name name-style="western"><surname>Greenhaff</surname><given-names>P.L.</given-names></name><name name-style="western"><surname>Hespel</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Israel</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Kraemer</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Spriet</surname><given-names>L.L.</given-names></name><name name-style="western"><surname>Tarnopolsky</surname><given-names>M.A.</given-names></name><etal/></person-group><article-title>American College of Sports Medicine roundtable. The physiological and health effects of oral creatine supplementation</article-title><source>Med. Sci. Sports Exerc.</source><year>2000</year><volume>32</volume><fpage>706</fpage><lpage>717</lpage><pub-id pub-id-type="doi">10.1097/00005768-200003000-00024</pub-id><pub-id pub-id-type="pmid">10731017</pub-id></element-citation></ref><ref id="B28-nutrients-17-02860"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marcotte-Ch&#233;nard</surname><given-names>A.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>B.</given-names></name><name name-style="western"><surname>Little</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Candow</surname><given-names>D.G.</given-names></name></person-group><article-title>Sarcopenia and type 2 diabetes: Pathophysiology and potential therapeutic lifestyle interventions</article-title><source>Diabetes Metab. Syndr. Clin. Res. Rev.</source><year>2023</year><volume>17</volume><fpage>102835</fpage><pub-id pub-id-type="doi">10.1016/j.dsx.2023.102835</pub-id><pub-id pub-id-type="pmid">37542749</pub-id></element-citation></ref><ref id="B29-nutrients-17-02860"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morley</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Abbatecola</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Argiles</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Baracos</surname><given-names>V.</given-names></name><name name-style="western"><surname>Bauer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bhasin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cederholm</surname><given-names>T.</given-names></name><name name-style="western"><surname>Coats</surname><given-names>A.J.S.</given-names></name><name name-style="western"><surname>Cummings</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Evans</surname><given-names>W.J.</given-names></name><etal/></person-group><article-title>Society on Sarcopenia, Cachexia and Wasting Disorders Trialist Workshop, Sarcopenia with limited mobility: An international consensus</article-title><source>J. Am. Med. Dir. Assoc.</source><year>2011</year><volume>12</volume><fpage>403</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1016/j.jamda.2011.04.014</pub-id><pub-id pub-id-type="pmid">21640657</pub-id><pub-id pub-id-type="pmcid">PMC5100674</pub-id></element-citation></ref><ref id="B30-nutrients-17-02860"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalinkovich</surname><given-names>A.</given-names></name><name name-style="western"><surname>Livshits</surname><given-names>G.</given-names></name></person-group><article-title>Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis</article-title><source>Ageing Res. Rev.</source><year>2017</year><volume>35</volume><fpage>200</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/j.arr.2016.09.008</pub-id><pub-id pub-id-type="pmid">27702700</pub-id></element-citation></ref><ref id="B31-nutrients-17-02860"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>X.</given-names></name><name name-style="western"><surname>Liao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>G.</given-names></name></person-group><article-title>Sarcopenia: Current insights into molecular mechanisms, diagnostics, and emerging interventional approaches</article-title><source>Int. J. Mol. Sci.</source><year>2025</year><volume>26</volume><elocation-id>6740</elocation-id><pub-id pub-id-type="doi">10.3390/ijms26146740</pub-id><pub-id pub-id-type="pmid">40724988</pub-id><pub-id pub-id-type="pmcid">PMC12295260</pub-id></element-citation></ref><ref id="B32-nutrients-17-02860"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Purnamasari</surname><given-names>D.</given-names></name><name name-style="western"><surname>Tetrasiwi</surname><given-names>E.N.</given-names></name><name name-style="western"><surname>Kartiko</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Astrella</surname><given-names>C.</given-names></name><name name-style="western"><surname>Husam</surname><given-names>K.</given-names></name><name name-style="western"><surname>Laksmi</surname><given-names>P.W.</given-names></name></person-group><article-title>Sarcopenia and chronic complications of type 2 diabetes mellitus</article-title><source>Rev. Diabet. Stud.</source><year>2022</year><volume>18</volume><fpage>157</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1900/RDS.2022.18.157</pub-id><pub-id pub-id-type="pmid">36309772</pub-id><pub-id pub-id-type="pmcid">PMC9652710</pub-id></element-citation></ref><ref id="B33-nutrients-17-02860"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Candow</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Forbes</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Chilibeck</surname><given-names>P.D.</given-names></name><name name-style="western"><surname>Cornish</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Antonio</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kreider</surname><given-names>R.B.</given-names></name></person-group><article-title>Effectiveness of creatine supplementation on aging muscle and bone: Focus on falls prevention and inflammation</article-title><source>J. Clin. Med.</source><year>2019</year><volume>8</volume><elocation-id>488</elocation-id><pub-id pub-id-type="doi">10.3390/jcm8040488</pub-id><pub-id pub-id-type="pmid">30978926</pub-id><pub-id pub-id-type="pmcid">PMC6518405</pub-id></element-citation></ref><ref id="B34-nutrients-17-02860"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Solis</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Artioli</surname><given-names>G.G.</given-names></name><name name-style="western"><surname>Gualano</surname><given-names>B.</given-names></name></person-group><article-title>Potential of creatine in glucose management and diabetes</article-title><source>Nutrients</source><year>2021</year><volume>13</volume><elocation-id>570</elocation-id><pub-id pub-id-type="doi">10.3390/nu13020570</pub-id><pub-id pub-id-type="pmid">33572228</pub-id><pub-id pub-id-type="pmcid">PMC7915263</pub-id></element-citation></ref><ref id="B35-nutrients-17-02860"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hulett</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Scalzo</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Reusch</surname><given-names>J.E.B.</given-names></name></person-group><article-title>Glucose Uptake by Skeletal Muscle within the Contexts of Type 2 Diabetes and Exercise: An Integrated Approach</article-title><source>Nutrients</source><year>2022</year><volume>14</volume><elocation-id>647</elocation-id><pub-id pub-id-type="doi">10.3390/nu14030647</pub-id><pub-id pub-id-type="pmid">35277006</pub-id><pub-id pub-id-type="pmcid">PMC8839578</pub-id></element-citation></ref><ref id="B36-nutrients-17-02860"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeFronzo</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Tripathy</surname><given-names>D.</given-names></name></person-group><article-title>Skeletal muscle insulin resistance is the primary defect in Type 2 diabetes</article-title><source>Diabetes Care</source><year>2009</year><volume>32</volume><issue>(Suppl. S2)</issue><fpage>S157</fpage><lpage>S163</lpage><pub-id pub-id-type="doi">10.2337/dc09-S302</pub-id><pub-id pub-id-type="pmid">19875544</pub-id><pub-id pub-id-type="pmcid">PMC2811436</pub-id></element-citation></ref><ref id="B37-nutrients-17-02860"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Merz</surname><given-names>K.E.</given-names></name><name name-style="western"><surname>Thurmond</surname><given-names>D.C.</given-names></name></person-group><article-title>Role of Skeletal Muscle in Insulin Resistance and Glucose Uptake</article-title><source>Compr. Physiol.</source><year>2020</year><volume>10</volume><fpage>785</fpage><lpage>809</lpage><pub-id pub-id-type="doi">10.1002/j.2040-4603.2020.tb00136.x</pub-id><pub-id pub-id-type="pmid">32940941</pub-id><pub-id pub-id-type="pmcid">PMC8074531</pub-id></element-citation></ref><ref id="B38-nutrients-17-02860"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baron</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Brechtel</surname><given-names>G.</given-names></name><name name-style="western"><surname>Wallace</surname><given-names>P.</given-names></name><name name-style="western"><surname>Edelman</surname><given-names>S.V.</given-names></name></person-group><article-title>Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans</article-title><source>Am. J. Physiol. Metab.</source><year>1988</year><volume>255</volume><issue-part>Pt 1</issue-part><fpage>E769</fpage><lpage>E774</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.1988.255.6.E769</pub-id><pub-id pub-id-type="pmid">3059816</pub-id></element-citation></ref><ref id="B39-nutrients-17-02860"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richter</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Hargreaves</surname><given-names>M.</given-names></name></person-group><article-title>Exercise, GLUT4, and skeletal muscle glucose uptake</article-title><source>Physiol. Rev.</source><year>2013</year><volume>93</volume><fpage>993</fpage><lpage>1017</lpage><pub-id pub-id-type="doi">10.1152/physrev.00038.2012</pub-id><pub-id pub-id-type="pmid">23899560</pub-id></element-citation></ref><ref id="B40-nutrients-17-02860"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>A Pan</surname><given-names>D.</given-names></name><name name-style="western"><surname>Lillioja</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kriketos</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Milner</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>A Baur</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bogardus</surname><given-names>C.</given-names></name><name name-style="western"><surname>Jenkins</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Storlien</surname><given-names>L.H.</given-names></name></person-group><article-title>Skeletal muscle triglyceride levels are inversely related to insulin action</article-title><source>Diabetes</source><year>1997</year><volume>46</volume><fpage>983</fpage><lpage>988</lpage><pub-id pub-id-type="doi">10.2337/diab.46.6.983</pub-id><pub-id pub-id-type="pmid">9166669</pub-id></element-citation></ref><ref id="B41-nutrients-17-02860"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krssak</surname><given-names>M.</given-names></name><name name-style="western"><surname>Petersen</surname><given-names>K.F.</given-names></name><name name-style="western"><surname>Dresner</surname><given-names>A.</given-names></name><name name-style="western"><surname>DiPietro</surname><given-names>L.</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Rothman</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Shulman</surname><given-names>G.I.</given-names></name><name name-style="western"><surname>Roden</surname><given-names>M.</given-names></name></person-group><article-title>Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: A 1H NMR spectroscopy study</article-title><source>Diabetologia</source><year>1999</year><volume>42</volume><fpage>113</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1007/s001250051123</pub-id><pub-id pub-id-type="pmid">10027589</pub-id></element-citation></ref><ref id="B42-nutrients-17-02860"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sachs</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zarini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kahn</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Perreault</surname><given-names>L.</given-names></name><name name-style="western"><surname>Phang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Newsom</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Strauss</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kerege</surname><given-names>A.</given-names></name><name name-style="western"><surname>Schoen</surname><given-names>J.A.</given-names></name><etal/></person-group><article-title>Intermuscular adipose tissue directly modulates skeletal muscle insulin sensitivity in humans</article-title><source>Am. J. Physiol. Metab.</source><year>2019</year><volume>316</volume><fpage>E866</fpage><lpage>E879</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00243.2018</pub-id><pub-id pub-id-type="pmid">30620635</pub-id><pub-id pub-id-type="pmcid">PMC6580171</pub-id></element-citation></ref><ref id="B43-nutrients-17-02860"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nishikawa</surname><given-names>T.</given-names></name><name name-style="western"><surname>Edelstein</surname><given-names>D.</given-names></name><name name-style="western"><surname>Du</surname><given-names>X.L.</given-names></name><name name-style="western"><surname>Yamagishi</surname><given-names>S.-I.</given-names></name><name name-style="western"><surname>Matsumura</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kaneda</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yorek</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Beebe</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Oates</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Hammes</surname><given-names>H.-P.</given-names></name><etal/></person-group><article-title>Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage</article-title><source>Nature</source><year>2000</year><volume>404</volume><fpage>787</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1038/35008121</pub-id><pub-id pub-id-type="pmid">10783895</pub-id></element-citation></ref><ref id="B44-nutrients-17-02860"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stanford</surname><given-names>K.I.</given-names></name><name name-style="western"><surname>Goodyear</surname><given-names>L.J.</given-names></name></person-group><article-title>Exercise and type 2 diabetes: Molecular mechanisms regulating glucose uptake in skeletal muscle</article-title><source>Adv. Physiol. Educ.</source><year>2014</year><volume>38</volume><fpage>308</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1152/advan.00080.2014</pub-id><pub-id pub-id-type="pmid">25434013</pub-id><pub-id pub-id-type="pmcid">PMC4315445</pub-id></element-citation></ref><ref id="B45-nutrients-17-02860"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>R.-S.</given-names></name><name name-style="western"><surname>Handy</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Loscalzo</surname><given-names>J.</given-names></name></person-group><article-title>NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism</article-title><source>Antioxid. Redox Signal.</source><year>2018</year><volume>28</volume><fpage>251</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1089/ars.2017.7216</pub-id><pub-id pub-id-type="pmid">28648096</pub-id><pub-id pub-id-type="pmcid">PMC5737637</pub-id></element-citation></ref><ref id="B46-nutrients-17-02860"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>M.P.</given-names></name></person-group><article-title>How mitochondria produce reactive oxygen species</article-title><source>Biochem. J.</source><year>2009</year><volume>417</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1042/BJ20081386</pub-id><pub-id pub-id-type="pmid">19061483</pub-id><pub-id pub-id-type="pmcid">PMC2605959</pub-id></element-citation></ref><ref id="B47-nutrients-17-02860"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kazemi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Afrasyabi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zadeh</surname><given-names>M.A.M.</given-names></name></person-group><article-title>The effects of high intensity interval training induced H2O2, Nrf2 changes on antioxidants factors in type 2 diabetes</article-title><source>J. Diabetes Metab. Disord.</source><year>2022</year><volume>23</volume><fpage>1829</fpage><lpage>1838</lpage><pub-id pub-id-type="doi">10.1007/s40200-022-01128-7</pub-id><pub-id pub-id-type="pmid">39610477</pub-id><pub-id pub-id-type="pmcid">PMC11599511</pub-id></element-citation></ref><ref id="B48-nutrients-17-02860"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patti</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Butte</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Crunkhorn</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cusi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Berria</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kashyap</surname><given-names>S.</given-names></name><name name-style="western"><surname>Miyazaki</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kohane</surname><given-names>I.</given-names></name><name name-style="western"><surname>Costello</surname><given-names>M.</given-names></name><name name-style="western"><surname>Saccone</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of <italic toggle="yes">PGC1</italic> and <italic toggle="yes">NRF1</italic></article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2003</year><volume>100</volume><fpage>8466</fpage><lpage>8471</lpage><pub-id pub-id-type="doi">10.1073/pnas.1032913100</pub-id><pub-id pub-id-type="pmid">12832613</pub-id><pub-id pub-id-type="pmcid">PMC166252</pub-id></element-citation></ref><ref id="B49-nutrients-17-02860"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meex</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Schrauwen-Hinderling</surname><given-names>V.B.</given-names></name><name name-style="western"><surname>Moonen-Kornips</surname><given-names>E.</given-names></name><name name-style="western"><surname>Schaart</surname><given-names>G.</given-names></name><name name-style="western"><surname>Mensink</surname><given-names>M.</given-names></name><name name-style="western"><surname>Phielix</surname><given-names>E.</given-names></name><name name-style="western"><surname>van de Weijer</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sels</surname><given-names>J.-P.</given-names></name><name name-style="western"><surname>Schrauwen</surname><given-names>P.</given-names></name><name name-style="western"><surname>Hesselink</surname><given-names>M.K.</given-names></name></person-group><article-title>Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity</article-title><source>Diabetes</source><year>2010</year><volume>59</volume><fpage>572</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.2337/db09-1322</pub-id><pub-id pub-id-type="pmid">20028948</pub-id><pub-id pub-id-type="pmcid">PMC2828651</pub-id></element-citation></ref><ref id="B50-nutrients-17-02860"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Oliveira</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>de Lima Ribeiro</surname><given-names>A.K.P.</given-names></name><name name-style="western"><surname>de Oliveira Silva</surname><given-names>D.D.</given-names></name><name name-style="western"><surname>Nunes</surname><given-names>E.F.C.</given-names></name><name name-style="western"><surname>Santos</surname><given-names>G.S.</given-names></name><name name-style="western"><surname>Kietzer</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>de Tarso Camillo de Carvalho</surname><given-names>P.</given-names></name></person-group><article-title>Physical Training on Glycemia and Oxidative Stress in Type 2 Diabetes: A Systematic Review</article-title><source>Rev. Bras. Med. Esporte</source><year>2020</year><volume>26</volume><fpage>70</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1590/1517-869220202601187572</pub-id></element-citation></ref><ref id="B51-nutrients-17-02860"><label>51.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>Who Guidelines on Physical Activity and Sedentary Behaviour</source><publisher-name>World Health Organization</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2020</year><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/publications/i/item/9789240015128" ext-link-type="uri">https://www.who.int/publications/i/item/9789240015128</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-08-10">(accessed on 10 August 2025)</date-in-citation></element-citation></ref><ref id="B52-nutrients-17-02860"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kirwan</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Sacks</surname><given-names>J.</given-names></name><name name-style="western"><surname>Nieuwoudt</surname><given-names>S.</given-names></name></person-group><article-title>The essential role of exercise in the management of type 2 diabetes</article-title><source>Clevel. Clin. J. Med.</source><year>2017</year><volume>84</volume><issue>(Suppl. S1)</issue><fpage>S15</fpage><lpage>S21</lpage><pub-id pub-id-type="doi">10.3949/ccjm.84.s1.03</pub-id><pub-id pub-id-type="pmcid">PMC5846677</pub-id><pub-id pub-id-type="pmid">28708479</pub-id></element-citation></ref><ref id="B53-nutrients-17-02860"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>H.</given-names></name><name name-style="western"><surname>Alkhawam</surname><given-names>H.</given-names></name><name name-style="western"><surname>Madanieh</surname><given-names>R.</given-names></name><name name-style="western"><surname>Shah</surname><given-names>N.</given-names></name><name name-style="western"><surname>E Kosmas</surname><given-names>C.</given-names></name><name name-style="western"><surname>Vittorio</surname><given-names>T.J.</given-names></name></person-group><article-title>Aerobic <italic toggle="yes">vs</italic> anaerobic exercise training effects on the cardiovascular system</article-title><source>World J. Cardiol.</source><year>2017</year><volume>9</volume><fpage>134</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.4330/wjc.v9.i2.134</pub-id><pub-id pub-id-type="pmid">28289526</pub-id><pub-id pub-id-type="pmcid">PMC5329739</pub-id></element-citation></ref><ref id="B54-nutrients-17-02860"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miranda-Tueros</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ramirez-Pe&#241;a</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cabanillas-Lazo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Paz-Ibarra</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Pinedo-Torres</surname><given-names>I.</given-names></name></person-group><article-title>Effects of aerobic exercise on components of the metabolic syndrome in older adults with type 2 diabetes mellitus: Systematic review and meta-analysis [Efectos del ejercicio aer&#243;bico sobre los componentes del s&#237;ndrome metab&#243;lico en adultos mayores con diabetes mellitus tipo 2: Revisi&#243;n sistem&#225;tica y metaan&#225;lisis]</article-title><source>Rev. Peru Med. Exp. Salud Publica</source><year>2024</year><volume>41</volume><fpage>146</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.17843/rpmesp.2024.412.12751</pub-id><pub-id pub-id-type="pmid">39166637</pub-id><pub-id pub-id-type="pmcid">PMC11300696</pub-id></element-citation></ref><ref id="B55-nutrients-17-02860"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cuthbertson</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Moore</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Sotres-Alvarez</surname><given-names>D.</given-names></name><name name-style="western"><surname>Heiss</surname><given-names>G.</given-names></name><name name-style="western"><surname>Isasi</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Mossavar-Rahmani</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Carlson</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Gallo</surname><given-names>L.C.</given-names></name><name name-style="western"><surname>Llabre</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Garcia-Bedoya</surname><given-names>O.L.</given-names></name><etal/></person-group><article-title>Associations of steps per day and step intensity with the risk of diabetes: The Hispanic Community Health Study / Study of Latinos (HCHS/SOL)</article-title><source>Int. J. Behav. Nutr. Phys. Act.</source><year>2022</year><volume>19</volume><fpage>46</fpage><pub-id pub-id-type="doi">10.1186/s12966-022-01284-2</pub-id><pub-id pub-id-type="pmid">35428253</pub-id><pub-id pub-id-type="pmcid">PMC9013106</pub-id></element-citation></ref><ref id="B56-nutrients-17-02860"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>D.-Q.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H.-J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>H.-M.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>X.-L.</given-names></name><name name-style="western"><surname>Du</surname><given-names>L.-Y.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>S.-M.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>W.-F.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H.-X.</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>Z.-Y.</given-names></name><etal/></person-group><article-title>Accelerometer-derived physical activity patterns and incident type 2 diabetes: A prospective cohort study</article-title><source>Int. J. Behav. Nutr. Phys. Act.</source><year>2025</year><volume>22</volume><fpage>38</fpage><pub-id pub-id-type="doi">10.1186/s12966-025-01734-7</pub-id><pub-id pub-id-type="pmid">40165316</pub-id><pub-id pub-id-type="pmcid">PMC11956271</pub-id></element-citation></ref><ref id="B57-nutrients-17-02860"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Xing</surname><given-names>Z.</given-names></name></person-group><article-title>Device-measured physical activity and type 2 diabetes mellitus risk</article-title><source>Front. Endocrinol.</source><year>2023</year><volume>14</volume><elocation-id>1275182</elocation-id><pub-id pub-id-type="doi">10.3389/fendo.2023.1275182</pub-id><pub-id pub-id-type="pmcid">PMC10764276</pub-id><pub-id pub-id-type="pmid">38179306</pub-id></element-citation></ref><ref id="B58-nutrients-17-02860"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tonga</surname><given-names>E.</given-names></name><name name-style="western"><surname>Worboys</surname><given-names>H.</given-names></name><name name-style="western"><surname>Evans</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Davies</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Ng</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Yates</surname><given-names>T.</given-names></name></person-group><article-title>Physical activity guidelines for adults with type 2 Diabetes: Systematic review</article-title><source>Diabetes Res. Clin. Pr.</source><year>2025</year><volume>220</volume><fpage>111982</fpage><pub-id pub-id-type="doi">10.1016/j.diabres.2024.111982</pub-id><pub-id pub-id-type="pmid">39746550</pub-id></element-citation></ref><ref id="B59-nutrients-17-02860"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sparks</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Johannsen</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>Church</surname><given-names>T.S.</given-names></name><name name-style="western"><surname>Earnest</surname><given-names>C.P.</given-names></name><name name-style="western"><surname>Moonen-Kornips</surname><given-names>E.</given-names></name><name name-style="western"><surname>Moro</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hesselink</surname><given-names>M.K.C.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Schrauwen</surname><given-names>P.</given-names></name></person-group><article-title>Nine months of combined training improves ex vivo skeletal muscle metabolism in individuals with type 2 diabetes</article-title><source>J. Clin. Endocrinol. Metab.</source><year>2013</year><volume>98</volume><fpage>1694</fpage><lpage>1702</lpage><pub-id pub-id-type="doi">10.1210/jc.2012-3874</pub-id><pub-id pub-id-type="pmid">23463651</pub-id><pub-id pub-id-type="pmcid">PMC3615199</pub-id></element-citation></ref><ref id="B60-nutrients-17-02860"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holten</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Zacho</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gaster</surname><given-names>M.</given-names></name><name name-style="western"><surname>Juel</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wojtaszewski</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Dela</surname><given-names>F.</given-names></name></person-group><article-title>Strength training increases insulin-mediated glucose uptake, glut4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes</article-title><source>Diabetes</source><year>2004</year><volume>53</volume><fpage>294</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.2337/diabetes.53.2.294</pub-id><pub-id pub-id-type="pmid">14747278</pub-id></element-citation></ref><ref id="B61-nutrients-17-02860"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chien</surname><given-names>Y.-H.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>C.-J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>D.-C.</given-names></name><name name-style="western"><surname>Chuang</surname><given-names>P.-H.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>H.-T.</given-names></name></person-group><article-title>Effects of 12-Week Progressive Sandbag Exercise Training on Glycemic Control and Muscle Strength in Patients with Type 2 Diabetes Mellitus Combined with Possible Sarcopenia</article-title><source>Int. J. Environ. Res. Public Health</source><year>2022</year><volume>19</volume><elocation-id>15009</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph192215009</pub-id><pub-id pub-id-type="pmid">36429728</pub-id><pub-id pub-id-type="pmcid">PMC9690442</pub-id></element-citation></ref><ref id="B62-nutrients-17-02860"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jansson</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>L.X.</given-names></name><name name-style="western"><surname>Lubans</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Duncan</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Plotnikoff</surname><given-names>R.C.</given-names></name></person-group><article-title>Effect of resistance training on HbA1c in adults with type 2 diabetes mellitus and the moderating effect of changes in muscular strength: A systematic review and meta-analysis</article-title><source>BMJ Open Diabetes Res. Care</source><year>2022</year><volume>10</volume><fpage>e002595</fpage><pub-id pub-id-type="doi">10.1136/bmjdrc-2021-002595</pub-id><pub-id pub-id-type="pmcid">PMC8915309</pub-id><pub-id pub-id-type="pmid">35273011</pub-id></element-citation></ref><ref id="B63-nutrients-17-02860"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pan</surname><given-names>B.</given-names></name><name name-style="western"><surname>Ge</surname><given-names>L.</given-names></name><name name-style="western"><surname>Xun</surname><given-names>Y.-Q.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.-J.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>C.-Y.</given-names></name><name name-style="western"><surname>Han</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zuo</surname><given-names>L.-Q.</given-names></name><name name-style="western"><surname>Shan</surname><given-names>H.-Q.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>K.-H.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>G.-W.</given-names></name><etal/></person-group><article-title>Exercise training modalities in patients with type 2 diabetes mellitus: A systematic review and network meta-analysis</article-title><source>Int. J. Behav. Nutr. Phys. Act.</source><year>2018</year><volume>15</volume><fpage>72</fpage><pub-id pub-id-type="doi">10.1186/s12966-018-0703-3</pub-id><pub-id pub-id-type="pmid">30045740</pub-id><pub-id pub-id-type="pmcid">PMC6060544</pub-id></element-citation></ref><ref id="B64-nutrients-17-02860"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amaravadi</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Maiya</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Vaishali</surname><given-names>K.</given-names></name><name name-style="western"><surname>Shastry</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Mendoza-Nu&#241;ez</surname><given-names>V.M.</given-names></name></person-group><article-title>Effectiveness of structured exercise program on insulin resistance and quality of life in type 2 diabetes mellitus&#8211;A randomized controlled trial</article-title><source>PLoS ONE</source><year>2024</year><volume>19</volume><elocation-id>e0302831</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0302831</pub-id><pub-id pub-id-type="pmid">38771888</pub-id><pub-id pub-id-type="pmcid">PMC11108169</pub-id></element-citation></ref><ref id="B65-nutrients-17-02860"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Han</surname><given-names>R.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>D.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Ge</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ni</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Exercise-induced improvement of glycemic fluctuation and its relationship with fat and muscle distribution in type 2 diabetes</article-title><source>J. Diabetes</source><year>2024</year><volume>16</volume><fpage>e13549</fpage><pub-id pub-id-type="doi">10.1111/1753-0407.13549</pub-id><pub-id pub-id-type="pmid">38584275</pub-id><pub-id pub-id-type="pmcid">PMC10999499</pub-id></element-citation></ref><ref id="B66-nutrients-17-02860"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henriksen</surname><given-names>E.J.</given-names></name></person-group><article-title>Invited Review: Effects of acute exercise and exercise training on insulin resistance</article-title><source>J. Appl. Physiol.</source><year>2002</year><volume>93</volume><fpage>788</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.01219.2001</pub-id><pub-id pub-id-type="pmid">12133893</pub-id></element-citation></ref><ref id="B67-nutrients-17-02860"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Robinson</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Sewell</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Hultman</surname><given-names>E.</given-names></name><name name-style="western"><surname>Greenhaff</surname><given-names>P.L.</given-names></name></person-group><article-title>Role of submaximal exercise in promoting creatine and glycogen accumulation in human skeletal muscle</article-title><source>J. Appl. Physiol.</source><year>1999</year><volume>87</volume><fpage>598</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1152/jappl.1999.87.2.598</pub-id><pub-id pub-id-type="pmid">10444618</pub-id></element-citation></ref><ref id="B68-nutrients-17-02860"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>King</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Dalsky</surname><given-names>G.P.</given-names></name><name name-style="western"><surname>Staten</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Clutter</surname><given-names>W.E.</given-names></name><name name-style="western"><surname>Van Houten</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Holloszy</surname><given-names>J.O.</given-names></name></person-group><article-title>Insulin action and secretion in en-durance-trained and untrained humans</article-title><source>J. Appl. Physiol.</source><year>1987</year><volume>63</volume><fpage>2247</fpage><lpage>2252</lpage><pub-id pub-id-type="doi">10.1152/jappl.1987.63.6.2247</pub-id><pub-id pub-id-type="pmid">3325486</pub-id></element-citation></ref><ref id="B69-nutrients-17-02860"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gan</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Kriketos</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Ellis</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Kraegen</surname><given-names>E.W.</given-names></name><name name-style="western"><surname>Chisholm</surname><given-names>D.J.</given-names></name></person-group><article-title>Changes in aerobic capacity and visceral fat but not myocyte lipid levels predict increased insulin action after exercise in overweight and obese men</article-title><source>Diabetes Care</source><year>2003</year><volume>26</volume><fpage>1706</fpage><lpage>1713</lpage><pub-id pub-id-type="doi">10.2337/diacare.26.6.1706</pub-id><pub-id pub-id-type="pmid">12766098</pub-id></element-citation></ref><ref id="B70-nutrients-17-02860"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Devlin</surname><given-names>J.T.</given-names></name><name name-style="western"><surname>Hirshman</surname><given-names>M.</given-names></name><name name-style="western"><surname>Horton</surname><given-names>E.D.</given-names></name><name name-style="western"><surname>Horton</surname><given-names>E.S.</given-names></name></person-group><article-title>Enhanced peripheral and splanchnic insulin sensitivity in NIDDM men after single bout of exercise</article-title><source>Diabetes</source><year>1987</year><volume>36</volume><fpage>434</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.2337/diab.36.4.434</pub-id><pub-id pub-id-type="pmid">3102297</pub-id></element-citation></ref><ref id="B71-nutrients-17-02860"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bruce</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Kriketos</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Cooney</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Hawley</surname><given-names>J.A.</given-names></name></person-group><article-title>Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with Type 2 diabetes</article-title><source>Diabetologia</source><year>2004</year><volume>47</volume><fpage>23</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1007/s00125-003-1265-7</pub-id><pub-id pub-id-type="pmid">14673522</pub-id></element-citation></ref><ref id="B72-nutrients-17-02860"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rocic</surname><given-names>B.</given-names></name><name name-style="western"><surname>Vucic</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mesic</surname><given-names>R.</given-names></name><name name-style="western"><surname>Rocic</surname><given-names>P.</given-names></name><name name-style="western"><surname>Coce</surname><given-names>F.</given-names></name></person-group><article-title>Hypoglycemic effect of creatine in insulin dependent diabetic patients</article-title><source>Diabetol Croat.</source><year>1995</year><volume>24</volume><fpage>117</fpage><lpage>120</lpage></element-citation></ref><ref id="B73-nutrients-17-02860"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pinto</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Botelho</surname><given-names>P.B.</given-names></name><name name-style="western"><surname>Pimentel</surname><given-names>G.D.</given-names></name><name name-style="western"><surname>Campos-Ferraz</surname><given-names>P.L.</given-names></name><name name-style="western"><surname>Mota</surname><given-names>J.F.</given-names></name></person-group><article-title>Creatine supplementation and glycemic control: A systematic review</article-title><source>Amino Acids</source><year>2016</year><volume>48</volume><fpage>2103</fpage><lpage>2129</lpage><pub-id pub-id-type="doi">10.1007/s00726-016-2277-1</pub-id><pub-id pub-id-type="pmid">27306768</pub-id></element-citation></ref><ref id="B74-nutrients-17-02860"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antonio</surname><given-names>J.</given-names></name><name name-style="western"><surname>Candow</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Forbes</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Gualano</surname><given-names>B.</given-names></name><name name-style="western"><surname>Jagim</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Kreider</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Rawson</surname><given-names>E.S.</given-names></name><name name-style="western"><surname>Smith-Ryan</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>VanDusseldorp</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Willoughby</surname><given-names>D.S.</given-names></name><etal/></person-group><article-title>Common questions and misconceptions about creatine supplementation: What does the scientific evidence really show?</article-title><source>J. Int. Soc. Sports Nutr.</source><year>2021</year><volume>18</volume><fpage>13</fpage><pub-id pub-id-type="doi">10.1186/s12970-021-00412-w</pub-id><pub-id pub-id-type="pmid">33557850</pub-id><pub-id pub-id-type="pmcid">PMC7871530</pub-id></element-citation></ref><ref id="B75-nutrients-17-02860"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amiri</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sheikholeslami-Vatani</surname><given-names>D.</given-names></name></person-group><article-title>The role of resistance training and creatine supplementation on oxidative stress, antioxidant defense, muscle strength, and quality of life in older adults</article-title><source>Front. Public Health</source><year>2023</year><volume>11</volume><elocation-id>1062832</elocation-id><pub-id pub-id-type="doi">10.3389/fpubh.2023.1062832</pub-id><pub-id pub-id-type="pmid">37206869</pub-id><pub-id pub-id-type="pmcid">PMC10189876</pub-id></element-citation></ref><ref id="B76-nutrients-17-02860"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamaguchi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Inami</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ishida</surname><given-names>H.</given-names></name><name name-style="western"><surname>Morito</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nagata</surname><given-names>N.</given-names></name><name name-style="western"><surname>Murayama</surname><given-names>M.</given-names></name></person-group><article-title>The Effect of Prior Creatine Intake for 28 Days on Accelerated Recovery from Exercise-Induced Muscle Damage: A Double-Blind, Randomized, Placebo-Controlled Trial</article-title><source>Nutrients</source><year>2024</year><volume>16</volume><elocation-id>896</elocation-id><pub-id pub-id-type="doi">10.3390/nu16060896</pub-id><pub-id pub-id-type="pmid">38542807</pub-id><pub-id pub-id-type="pmcid">PMC10975653</pub-id></element-citation></ref><ref id="B77-nutrients-17-02860"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lanhers</surname><given-names>C.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>B.</given-names></name><name name-style="western"><surname>Naughton</surname><given-names>G.</given-names></name><name name-style="western"><surname>Trousselard</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lesage</surname><given-names>F.-X.</given-names></name><name name-style="western"><surname>Dutheil</surname><given-names>F.</given-names></name></person-group><article-title>Creatine Supplementation and Lower Limb Strength Performance: A Systematic Review and Meta-Analyses</article-title><source>Sports Med.</source><year>2015</year><volume>45</volume><fpage>1285</fpage><lpage>1294</lpage><pub-id pub-id-type="doi">10.1007/s40279-015-0337-4</pub-id><pub-id pub-id-type="pmid">25946994</pub-id></element-citation></ref><ref id="B78-nutrients-17-02860"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lanhers</surname><given-names>C.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>B.</given-names></name><name name-style="western"><surname>Naughton</surname><given-names>G.</given-names></name><name name-style="western"><surname>Trousselard</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lesage</surname><given-names>F.-X.</given-names></name><name name-style="western"><surname>Dutheil</surname><given-names>F.</given-names></name></person-group><article-title>Creatine Supplementation and Upper Limb Strength Performance: A Systematic Review and Meta-Analysis</article-title><source>Sports Med.</source><year>2017</year><volume>47</volume><fpage>163</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1007/s40279-016-0571-4</pub-id><pub-id pub-id-type="pmid">27328852</pub-id></element-citation></ref><ref id="B79-nutrients-17-02860"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mielgo-Ayuso</surname><given-names>J.</given-names></name><name name-style="western"><surname>Calleja-Gonzalez</surname><given-names>J.</given-names></name><name name-style="western"><surname>Marqu&#233;s-Jim&#233;nez</surname><given-names>D.</given-names></name><name name-style="western"><surname>Caballero-Garc&#237;a</surname><given-names>A.</given-names></name><name name-style="western"><surname>C&#243;rdova</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fern&#225;ndez-L&#225;zaro</surname><given-names>D.</given-names></name></person-group><article-title>Effects of Creatine Supplementation on Athletic Performance in Soccer Players: A Systematic Review and Meta-Analysis</article-title><source>Nutrients</source><year>2019</year><volume>11</volume><elocation-id>757</elocation-id><pub-id pub-id-type="doi">10.3390/nu11040757</pub-id><pub-id pub-id-type="pmid">30935142</pub-id><pub-id pub-id-type="pmcid">PMC6520963</pub-id></element-citation></ref><ref id="B80-nutrients-17-02860"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Law</surname><given-names>Y.L.L.</given-names></name><name name-style="western"><surname>Ong</surname><given-names>W.S.</given-names></name><name name-style="western"><surname>GillianYap</surname><given-names>T.L.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>S.C.J.</given-names></name><name name-style="western"><surname>Von Chia</surname><given-names>E.</given-names></name></person-group><article-title>Effects of Two and Five Days of Creatine Loading on Muscular Strength and Anaerobic Power in Trained Athletes</article-title><source>J. Strength Cond. Res.</source><year>2009</year><volume>23</volume><fpage>906</fpage><lpage>914</lpage><pub-id pub-id-type="doi">10.1519/JSC.0b013e3181a06c59</pub-id><pub-id pub-id-type="pmid">19387386</pub-id></element-citation></ref><ref id="B81-nutrients-17-02860"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>S&#246;derlund</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hultman</surname><given-names>E.</given-names></name></person-group><article-title>Elevation of creatine in resting and exercised muscle of normal subjects by crea-tine supplementation</article-title><source>Clin. Sci.</source><year>1992</year><volume>83</volume><fpage>367</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1042/cs0830367</pub-id><pub-id pub-id-type="pmid">1327657</pub-id></element-citation></ref><ref id="B82-nutrients-17-02860"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wax</surname><given-names>B.</given-names></name><name name-style="western"><surname>Kerksick</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Jagim</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Mayo</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Lyons</surname><given-names>B.C.</given-names></name><name name-style="western"><surname>Kreider</surname><given-names>R.B.</given-names></name></person-group><article-title>Creatine for Exercise and Sports Performance, with Recovery Considerations for Healthy Populations</article-title><source>Nutrients</source><year>2021</year><volume>13</volume><elocation-id>1915</elocation-id><pub-id pub-id-type="doi">10.3390/nu13061915</pub-id><pub-id pub-id-type="pmid">34199588</pub-id><pub-id pub-id-type="pmcid">PMC8228369</pub-id></element-citation></ref><ref id="B83-nutrients-17-02860"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaviani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Abassi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Chilibeck</surname><given-names>P.D.</given-names></name></person-group><article-title>Creatine monohydrate supplementation during eight weeks of progressive resistance training increases strength in as little as two weeks without reducing markers of muscle damage</article-title><source>J. Sports Med. Phys. Fit.</source><year>2019</year><volume>59</volume><fpage>608</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.23736/S0022-4707.18.08406-2</pub-id><pub-id pub-id-type="pmid">29722252</pub-id></element-citation></ref><ref id="B84-nutrients-17-02860"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kreider</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Kalman</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Antonio</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ziegenfuss</surname><given-names>T.N.</given-names></name><name name-style="western"><surname>Wildman</surname><given-names>R.</given-names></name><name name-style="western"><surname>Collins</surname><given-names>R.</given-names></name><name name-style="western"><surname>Candow</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Kleiner</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Almada</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Lopez</surname><given-names>H.L.</given-names></name></person-group><article-title>International Society of Sports Nutrition position stand: Safety and efficacy of creatine supplementation in exercise, sport, and medicine</article-title><source>J. Int. Soc. Sports Nutr.</source><year>2017</year><volume>14</volume><fpage>18</fpage><pub-id pub-id-type="doi">10.1186/s12970-017-0173-z</pub-id><pub-id pub-id-type="pmid">28615996</pub-id><pub-id pub-id-type="pmcid">PMC5469049</pub-id></element-citation></ref><ref id="B85-nutrients-17-02860"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chilibeck</surname><given-names>P.D.</given-names></name><name name-style="western"><surname>Kaviani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Candow</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>A Zello</surname><given-names>G.</given-names></name></person-group><article-title>Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: A meta-analysis</article-title><source>Open Access J. Sports Med.</source><year>2017</year><volume>8</volume><fpage>213</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.2147/OAJSM.S123529</pub-id><pub-id pub-id-type="pmid">29138605</pub-id><pub-id pub-id-type="pmcid">PMC5679696</pub-id></element-citation></ref><ref id="B86-nutrients-17-02860"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burke</surname><given-names>R.</given-names></name><name name-style="western"><surname>Pi&#241;ero</surname><given-names>A.</given-names></name><name name-style="western"><surname>Coleman</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mohan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sapuppo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Augustin</surname><given-names>F.</given-names></name><name name-style="western"><surname>Aragon</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Candow</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Forbes</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Swinton</surname><given-names>P.</given-names></name><etal/></person-group><article-title>The Effects of Creatine Supplementation Combined with Resistance Training on Regional Measures of Muscle Hypertrophy: A Systematic Review with Meta-Analysis</article-title><source>Nutrients</source><year>2023</year><volume>15</volume><elocation-id>2116</elocation-id><pub-id pub-id-type="doi">10.3390/nu15092116</pub-id><pub-id pub-id-type="pmid">37432300</pub-id><pub-id pub-id-type="pmcid">PMC10180745</pub-id></element-citation></ref><ref id="B87-nutrients-17-02860"><label>87.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Schoenfeld</surname><given-names>B.</given-names></name></person-group><source>Science and Development of Muscle Hypertrophy</source><edition>2nd ed.</edition><publisher-name>Human Kinetics</publisher-name><publisher-loc>Champaign, IL, USA</publisher-loc><year>2020</year></element-citation></ref><ref id="B88-nutrients-17-02860"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Govers</surname><given-names>R.</given-names></name></person-group><article-title>Molecular mechanisms of GLUT4 regulation in adipocytes</article-title><source>Diabetes Metab.</source><year>2014</year><volume>40</volume><fpage>400</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/j.diabet.2014.01.005</pub-id><pub-id pub-id-type="pmid">24656589</pub-id></element-citation></ref><ref id="B89-nutrients-17-02860"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kennedy</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Hirshman</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Gervino</surname><given-names>E.V.</given-names></name><name name-style="western"><surname>Ocel</surname><given-names>J.V.</given-names></name><name name-style="western"><surname>A Forse</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hoenig</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Aronson</surname><given-names>D.</given-names></name><name name-style="western"><surname>Goodyear</surname><given-names>L.J.</given-names></name><name name-style="western"><surname>Horton</surname><given-names>E.S.</given-names></name></person-group><article-title>Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes</article-title><source>Diabetes</source><year>1999</year><volume>48</volume><fpage>1192</fpage><lpage>1197</lpage><pub-id pub-id-type="doi">10.2337/diabetes.48.5.1192</pub-id><pub-id pub-id-type="pmid">10331428</pub-id></element-citation></ref><ref id="B90-nutrients-17-02860"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Derave</surname><given-names>W.</given-names></name><name name-style="western"><surname>Eijnde</surname><given-names>B.O.</given-names></name><name name-style="western"><surname>Verbessem</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ramaekers</surname><given-names>M.</given-names></name><name name-style="western"><surname>Van Leemputte</surname><given-names>M.</given-names></name><name name-style="western"><surname>Richter</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Hespel</surname><given-names>P.</given-names></name></person-group><article-title>Combined creatine and protein supplementation in conjunction with resistance training promotes muscle GLUT-4 content and glucose tolerance in humans</article-title><source>J. Appl. Physiol.</source><year>2003</year><volume>94</volume><fpage>1910</fpage><lpage>1916</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00977.2002</pub-id><pub-id pub-id-type="pmid">12524381</pub-id></element-citation></ref><ref id="B91-nutrients-17-02860"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gualano</surname><given-names>B.</given-names></name><name name-style="western"><surname>Novaes</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Artioli</surname><given-names>G.G.</given-names></name><name name-style="western"><surname>Freire</surname><given-names>T.O.</given-names></name><name name-style="western"><surname>Coelho</surname><given-names>D.F.</given-names></name><name name-style="western"><surname>Scagliusi</surname><given-names>F.B.</given-names></name><name name-style="western"><surname>Rogeri</surname><given-names>P.S.</given-names></name><name name-style="western"><surname>Roschel</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ugrinowitsch</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lancha</surname><given-names>A.H.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Effects of creatine supplementation on glucose tolerance and insulin sensitivity in sedentary healthy males undergoing aerobic training</article-title><source>Amino Acids</source><year>2008</year><volume>34</volume><fpage>245</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1007/s00726-007-0508-1</pub-id><pub-id pub-id-type="pmid">17396216</pub-id></element-citation></ref><ref id="B92-nutrients-17-02860"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliveira</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Antunes</surname><given-names>B.d.M.M.</given-names></name><name name-style="western"><surname>Gomes</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Lira</surname><given-names>F.S.</given-names></name><name name-style="western"><surname>Pimentel</surname><given-names>G.D.</given-names></name><name name-style="western"><surname>Boul&#233;</surname><given-names>N.G.</given-names></name><name name-style="western"><surname>Mota</surname><given-names>J.F.</given-names></name></person-group><article-title>Creatine supplementation does not promote additional effects on inflammation and insulin resistance in older adults: A pilot randomized, double-blind, placebo-controlled trial</article-title><source>Clin. Nutr. ESPEN</source><year>2020</year><volume>38</volume><fpage>94</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.clnesp.2020.05.024</pub-id><pub-id pub-id-type="pmid">32690185</pub-id></element-citation></ref><ref id="B93-nutrients-17-02860"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alves</surname><given-names>C.R.R.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>de Siqueira-Filho</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Lancha</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>Gualano</surname><given-names>B.</given-names></name></person-group><article-title>Creatine-induced glucose uptake in type 2 diabetes: A role for AMPK-&#945;?</article-title><source>Amino Acids</source><year>2012</year><volume>43</volume><fpage>1803</fpage><lpage>1807</lpage><pub-id pub-id-type="doi">10.1007/s00726-012-1246-6</pub-id><pub-id pub-id-type="pmid">22349765</pub-id></element-citation></ref><ref id="B94-nutrients-17-02860"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Collins</surname><given-names>J.</given-names></name><name name-style="western"><surname>Longhurst</surname><given-names>G.</given-names></name><name name-style="western"><surname>Roschel</surname><given-names>H.</given-names></name><name name-style="western"><surname>Gualano</surname><given-names>B.</given-names></name></person-group><article-title>Resistance Training and Co-supplementation with Creatine and Protein in Older Subjects with Frailty</article-title><source>J. Frailty Aging</source><year>2016</year><volume>5</volume><fpage>126</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.14283/jfa.2016.85</pub-id><pub-id pub-id-type="pmid">27224505</pub-id></element-citation></ref><ref id="B95-nutrients-17-02860"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newman</surname><given-names>J.E.N.</given-names></name><name name-style="western"><surname>Hargreaves</surname><given-names>M.</given-names></name><name name-style="western"><surname>Garnham</surname><given-names>A.</given-names></name><name name-style="western"><surname>Snow</surname><given-names>R.J.</given-names></name></person-group><article-title>Effect of creatine ingestion on glucose tolerance and insulin sensitivity in men</article-title><source>Med. Sci. Sports Exerc.</source><year>2003</year><volume>35</volume><fpage>69</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1097/00005768-200301000-00012</pub-id><pub-id pub-id-type="pmid">12544638</pub-id></element-citation></ref><ref id="B96-nutrients-17-02860"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>VAN Loon</surname><given-names>L.J.C.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>R.</given-names></name><name name-style="western"><surname>Oosterlaar</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Cameron-Smith</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hargreaves</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wagenmakers</surname><given-names>A.J.M.</given-names></name><name name-style="western"><surname>Snow</surname><given-names>R.</given-names></name></person-group><article-title>Creatine supplementation increases glycogen storage but not GLUT-4 expression in human skeletal muscle</article-title><source>Clin. Sci.</source><year>2004</year><volume>106</volume><fpage>99</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1042/CS20030116</pub-id><pub-id pub-id-type="pmid">14507259</pub-id></element-citation></ref><ref id="B97-nutrients-17-02860"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Z.-P.</given-names></name><name name-style="western"><surname>Stephens</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Murthy</surname><given-names>S.</given-names></name><name name-style="western"><surname>Canny</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Hargreaves</surname><given-names>M.</given-names></name><name name-style="western"><surname>Witters</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Kemp</surname><given-names>B.E.</given-names></name><name name-style="western"><surname>McConell</surname><given-names>G.K.</given-names></name></person-group><article-title>Effect of exercise intensity on skeletal muscle AMPK signaling in humans</article-title><source>Diabetes</source><year>2003</year><volume>52</volume><fpage>2205</fpage><lpage>2212</lpage><pub-id pub-id-type="doi">10.2337/diabetes.52.9.2205</pub-id><pub-id pub-id-type="pmid">12941758</pub-id></element-citation></ref><ref id="B98-nutrients-17-02860"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Winder</surname><given-names>W.W.</given-names></name></person-group><article-title>Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle</article-title><source>J. Appl. Physiol.</source><year>2001</year><volume>91</volume><fpage>1017</fpage><lpage>1028</lpage><pub-id pub-id-type="doi">10.1152/jappl.2001.91.3.1017</pub-id><pub-id pub-id-type="pmid">11509493</pub-id></element-citation></ref><ref id="B99-nutrients-17-02860"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vega</surname><given-names>J.</given-names></name><name name-style="western"><surname>Huidobro</surname><given-names>E.J.P.</given-names></name></person-group><article-title>Efectos en la funci&#243;n renal de la suplementaci&#243;n de creatina con fines deportivos [Effects of creatine supplementation on renal function]</article-title><source>Rev. Medica Chile</source><year>2019</year><volume>147</volume><fpage>628</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.4067/S0034-98872019000500628</pub-id><pub-id pub-id-type="pmid">31859895</pub-id></element-citation></ref><ref id="B100-nutrients-17-02860"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hultman</surname><given-names>E.</given-names></name><name name-style="western"><surname>Soderlund</surname><given-names>K.</given-names></name><name name-style="western"><surname>Timmons</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Cederblad</surname><given-names>G.</given-names></name><name name-style="western"><surname>Greenhaff</surname><given-names>P.L.</given-names></name></person-group><article-title>Muscle creatine loading in men</article-title><source>J. Appl. Physiol. (1985)</source><year>1996</year><volume>81</volume><fpage>232</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1152/jappl.1996.81.1.232</pub-id><pub-id pub-id-type="pmid">8828669</pub-id></element-citation></ref><ref id="B101-nutrients-17-02860"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naidu</surname><given-names>M.</given-names></name><name name-style="western"><surname>de Guingand</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Hunter</surname><given-names>G.</given-names></name><name name-style="western"><surname>Tran</surname><given-names>N.T.</given-names></name><name name-style="western"><surname>Snow</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Kirkpatrick</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Ellery</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>K.R.</given-names></name></person-group><article-title>Open Label, Dose Escalation Trial of Creatine Monohydrate in Pregnancy</article-title><source>J. Int. Soc. Sports Nutr.</source><year>2025</year><volume>22</volume><issue>(Suppl. S1)</issue><fpage>2533652</fpage><pub-id pub-id-type="doi">10.1080/15502783.2025.2533652</pub-id></element-citation></ref><ref id="B102-nutrients-17-02860"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hall</surname><given-names>M.</given-names></name><name name-style="western"><surname>Trojian</surname><given-names>T.H.</given-names></name></person-group><article-title>Creatine supplementation</article-title><source>Optom. Vis. Sci.</source><year>2013</year><volume>12</volume><fpage>240</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1249/JSR.0b013e31829cdff2</pub-id><pub-id pub-id-type="pmid">23851411</pub-id></element-citation></ref><ref id="B103-nutrients-17-02860"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vandenberghe</surname><given-names>K.</given-names></name><name name-style="western"><surname>Goris</surname><given-names>M.</given-names></name><name name-style="western"><surname>Van Hecke</surname><given-names>P.</given-names></name><name name-style="western"><surname>Van Leemputte</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vangerven</surname><given-names>L.</given-names></name><name name-style="western"><surname>Hespel</surname><given-names>P.</given-names></name></person-group><article-title>Long-term creatine intake is beneficial to muscle performance during resistance training</article-title><source>J. Appl. Physiol.</source><year>1997</year><volume>83</volume><fpage>2055</fpage><lpage>2063</lpage><pub-id pub-id-type="doi">10.1152/jappl.1997.83.6.2055</pub-id><pub-id pub-id-type="pmid">9390981</pub-id></element-citation></ref><ref id="B104-nutrients-17-02860"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lobo</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Tritto</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>da Silva</surname><given-names>L.R.</given-names></name><name name-style="western"><surname>de Oliveira</surname><given-names>P.B.</given-names></name><name name-style="western"><surname>Benatti</surname><given-names>F.B.</given-names></name><name name-style="western"><surname>Roschel</surname><given-names>H.</given-names></name><name name-style="western"><surname>Nie&#223;</surname><given-names>B.</given-names></name><name name-style="western"><surname>Gualano</surname><given-names>B.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>R.M.R.</given-names></name></person-group><article-title>Effects of long-term low-dose dietary creatine supplementation in older women</article-title><source>Exp. Gerontol.</source><year>2015</year><volume>70</volume><fpage>97</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1016/j.exger.2015.07.012</pub-id><pub-id pub-id-type="pmid">26192975</pub-id></element-citation></ref><ref id="B105-nutrients-17-02860"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Candow</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Little</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Chilibeck</surname><given-names>P.D.</given-names></name><name name-style="western"><surname>Abeysekara</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zello</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Kazachkov</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cornish</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>P.H.</given-names></name></person-group><article-title>Low-Dose creatine combined with protein during resistance training in older men</article-title><source>Med. Sci. Sports Exerc.</source><year>2008</year><volume>40</volume><fpage>1645</fpage><lpage>1652</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e318176b310</pub-id><pub-id pub-id-type="pmid">18685526</pub-id></element-citation></ref><ref id="B106-nutrients-17-02860"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>G.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name></person-group><article-title>Amino acids regulating skeletal muscle metabolism: Mechanisms of action, physical training dosage recommendations and adverse effects</article-title><source>Nutr. Metab.</source><year>2024</year><volume>21</volume><fpage>41</fpage><pub-id pub-id-type="doi">10.1186/s12986-024-00820-0</pub-id><pub-id pub-id-type="pmcid">PMC11220999</pub-id><pub-id pub-id-type="pmid">38956658</pub-id></element-citation></ref><ref id="B107-nutrients-17-02860"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Candow</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Ostojic</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Chilibeck</surname><given-names>P.D.</given-names></name><name name-style="western"><surname>Longobardi</surname><given-names>I.</given-names></name><name name-style="western"><surname>Gualano</surname><given-names>B.</given-names></name><name name-style="western"><surname>Tarnopolsky</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Wallimann</surname><given-names>T.</given-names></name><name name-style="western"><surname>Moriarty</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kreider</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Forbes</surname><given-names>S.C.</given-names></name><etal/></person-group><article-title>Creatine monohydrate supplementation for older adults and clinical populations</article-title><source>J. Int. Soc. Sports Nutr.</source><year>2025</year><volume>22</volume><issue>(Suppl. S1)</issue><fpage>2534130</fpage><pub-id pub-id-type="doi">10.1080/15502783.2025.2534130</pub-id><pub-id pub-id-type="pmid">40673730</pub-id><pub-id pub-id-type="pmcid">PMC12272710</pub-id></element-citation></ref><ref id="B108-nutrients-17-02860"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Almeida</surname><given-names>D.</given-names></name><name name-style="western"><surname>Colombini</surname><given-names>A.</given-names></name><name name-style="western"><surname>Machado</surname><given-names>M.</given-names></name></person-group><article-title>Creatine supplementation improves performance, but is it safe? Double-blind placebo-controlled study</article-title><source>J. Sports Med. Phys. Fit.</source><year>2020</year><volume>60</volume><fpage>1034</fpage><lpage>1039</lpage><pub-id pub-id-type="doi">10.23736/S0022-4707.20.10437-7</pub-id><pub-id pub-id-type="pmid">32597619</pub-id></element-citation></ref><ref id="B109-nutrients-17-02860"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferreira</surname><given-names>L.G.</given-names></name><name name-style="western"><surname>Bergamaschi</surname><given-names>C.D.T.</given-names></name><name name-style="western"><surname>Lazaretti-Castro</surname><given-names>M.</given-names></name><name name-style="western"><surname>Heilberg</surname><given-names>I.P.</given-names></name></person-group><article-title>Effects of creatine supplementation on body composition and renal function in rats</article-title><source>Med. Sci. Sports Exerc.</source><year>2005</year><volume>37</volume><fpage>1525</fpage><lpage>1529</lpage><pub-id pub-id-type="doi">10.1249/01.mss.0000177555.94271.44</pub-id><pub-id pub-id-type="pmid">16177604</pub-id></element-citation></ref><ref id="B110-nutrients-17-02860"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baracho</surname><given-names>N.C.D.V.</given-names></name><name name-style="western"><surname>de Castro</surname><given-names>L.P.</given-names></name><name name-style="western"><surname>Borges</surname><given-names>N.d.C.</given-names></name><name name-style="western"><surname>Laira</surname><given-names>P.B.</given-names></name></person-group><article-title>Study of renal and hepatic toxicity in rats supplemented with creatine</article-title><source>Acta Cir. Bras.</source><year>2015</year><volume>30</volume><fpage>313</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1590/S0102-865020150050000002</pub-id><pub-id pub-id-type="pmid">26016930</pub-id></element-citation></ref><ref id="B111-nutrients-17-02860"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poortmans</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Auquier</surname><given-names>H.</given-names></name><name name-style="western"><surname>Renaut</surname><given-names>V.</given-names></name><name name-style="western"><surname>Durussel</surname><given-names>A.</given-names></name><name name-style="western"><surname>Saugy</surname><given-names>M.</given-names></name><name name-style="western"><surname>Brisson</surname><given-names>G.R.</given-names></name></person-group><article-title>Effect of short-term creatine supplementation on renal responses in men</article-title><source>Eur. J. Appl. Physiol.</source><year>1997</year><volume>76</volume><fpage>566</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1007/s004210050291</pub-id><pub-id pub-id-type="pmid">9404870</pub-id></element-citation></ref><ref id="B112-nutrients-17-02860"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kreider</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Melton</surname><given-names>C.</given-names></name><name name-style="western"><surname>Rasmussen</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Greenwood</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lancaster</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cantler</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Milnor</surname><given-names>P.</given-names></name><name name-style="western"><surname>Almada</surname><given-names>A.L.</given-names></name></person-group><article-title>Long-term creatine supplementation does not significantly affect clinical markers of health in athletes</article-title><source>Mol. Cell Biochem.</source><year>2003</year><volume>244</volume><fpage>95</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1023/A:1022469320296</pub-id><pub-id pub-id-type="pmid">12701816</pub-id></element-citation></ref><ref id="B113-nutrients-17-02860"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Persky</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Rawson</surname><given-names>E.S.</given-names></name></person-group><article-title>Safety of creatine supplementation</article-title><source>Subcell Biochem.</source><year>2007</year><volume>46</volume><fpage>275</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1007/978-1-4020-6486-9_14</pub-id><pub-id pub-id-type="pmid">18652082</pub-id></element-citation></ref><ref id="B114-nutrients-17-02860"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thorsteinsdottir</surname><given-names>B.</given-names></name><name name-style="western"><surname>Grande</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Garovic</surname><given-names>V.D.</given-names></name></person-group><article-title>Acute renal failure in a young weight lifter taking multiple food supplements, including creatine monohydrate</article-title><source>J. Ren. Nutr.</source><year>2006</year><volume>16</volume><fpage>341</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1053/j.jrn.2006.04.025</pub-id><pub-id pub-id-type="pmid">17046619</pub-id></element-citation></ref><ref id="B115-nutrients-17-02860"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barisic</surname><given-names>N.</given-names></name><name name-style="western"><surname>Bernert</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ipsiroglu</surname><given-names>O.</given-names></name><name name-style="western"><surname>Stromberger</surname><given-names>C.</given-names></name><name name-style="western"><surname>M&#227;&#188;Ller</surname><given-names>T.</given-names></name><name name-style="western"><surname>Gruber</surname><given-names>S.</given-names></name><name name-style="western"><surname>Prayer</surname><given-names>D.</given-names></name><name name-style="western"><surname>Moser</surname><given-names>E.</given-names></name><name name-style="western"><surname>Bittner</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>St&#246;ckler-Ipsiroglu</surname><given-names>S.</given-names></name></person-group><article-title>Effects of oral creatine supplementation in a patient with melas phenotype and associated nephropathy</article-title><source>Neuropediatrics</source><year>2002</year><volume>33</volume><fpage>157</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1055/s-2002-33679</pub-id><pub-id pub-id-type="pmid">12200746</pub-id></element-citation></ref><ref id="B116-nutrients-17-02860"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poortmans</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Francaux</surname><given-names>M.</given-names></name></person-group><article-title>Long-term oral creatine supplementation does not impair renal function in healthy athletes</article-title><source>Med. Sci. Sports Exerc.</source><year>1999</year><volume>31</volume><fpage>1108</fpage><lpage>1110</lpage><pub-id pub-id-type="doi">10.1097/00005768-199908000-00005</pub-id><pub-id pub-id-type="pmid">10449011</pub-id></element-citation></ref><ref id="B117-nutrients-17-02860"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Groeneveld</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Beijer</surname><given-names>C.</given-names></name><name name-style="western"><surname>Veldink</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Kalmijn</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wokke</surname><given-names>J.H.J.</given-names></name><name name-style="western"><surname>Berg</surname><given-names>L.H.v.D.</given-names></name></person-group><article-title>Few adverse effects of long-term creatine supplementation in a placebo-controlled trial</article-title><source>Int. J. Sports Med.</source><year>2005</year><volume>26</volume><fpage>307</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1055/s-2004-817917</pub-id><pub-id pub-id-type="pmid">15795816</pub-id></element-citation></ref><ref id="B118-nutrients-17-02860"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wyss</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kaddurah-Daouk</surname><given-names>R.</given-names></name></person-group><article-title>Creatine and creatinine metabolism</article-title><source>Physiol. Rev.</source><year>2000</year><volume>80</volume><fpage>1107</fpage><lpage>1213</lpage><pub-id pub-id-type="doi">10.1152/physrev.2000.80.3.1107</pub-id><pub-id pub-id-type="pmid">10893433</pub-id></element-citation></ref><ref id="B119-nutrients-17-02860"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hong</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ling</surname><given-names>K.</given-names></name></person-group><article-title>Exploring the relationship between creatine supplementation and renal function: Insights from Mendelian randomization analysis</article-title><source>Ren. Fail.</source><year>2024</year><volume>46</volume><fpage>2364762</fpage><pub-id pub-id-type="doi">10.1080/0886022X.2024.2364762</pub-id><pub-id pub-id-type="pmid">38874125</pub-id><pub-id pub-id-type="pmcid">PMC11232645</pub-id></element-citation></ref><ref id="B120-nutrients-17-02860"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rawson</surname><given-names>E.S.</given-names></name><name name-style="western"><surname>Clarkson</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Price</surname><given-names>T.B.</given-names></name><name name-style="western"><surname>Miles</surname><given-names>M.P.</given-names></name></person-group><article-title>Differential response of muscle phosphocreatine to creatine supplementation in young and old subjects</article-title><source>Acta Physiol. Scand.</source><year>2002</year><volume>174</volume><fpage>57</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1046/j.1365-201x.2002.00924.x</pub-id><pub-id pub-id-type="pmid">11851597</pub-id></element-citation></ref><ref id="B121-nutrients-17-02860"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seper</surname><given-names>V.</given-names></name><name name-style="western"><surname>Korovljev</surname><given-names>D.</given-names></name><name name-style="western"><surname>Todorovic</surname><given-names>N.</given-names></name><name name-style="western"><surname>Stajer</surname><given-names>V.</given-names></name><name name-style="western"><surname>Ostojic</surname><given-names>J.</given-names></name><name name-style="western"><surname>Nesic</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ostojic</surname><given-names>S.M.</given-names></name></person-group><article-title>Guanidinoacetate-Creatine Supplementation Improves Functional Performance and Muscle and Brain Bioenergetics in the Elderly: A Pilot Study</article-title><source>Ann. Nutr. Metab.</source><year>2021</year><volume>77</volume><fpage>244</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1159/000518499</pub-id><pub-id pub-id-type="pmid">34515048</pub-id></element-citation></ref><ref id="B122-nutrients-17-02860"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gil</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Hines</surname><given-names>K.</given-names></name><name name-style="western"><surname>Bonilla</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Kreider</surname><given-names>R.B.</given-names></name></person-group><article-title>Safety of Creatine Supplementation: Analysis of the Frequency of Reported Side Effects in Clinical Trials</article-title><source>J. Int. Soc. Sports Nutr.</source><year>2025</year><volume>22</volume><issue>(Suppl. S1)</issue><fpage>2533688</fpage><pub-id pub-id-type="doi">10.1080/15502783.2025.2533688</pub-id><pub-id pub-id-type="pmcid">PMC11983583</pub-id><pub-id pub-id-type="pmid">40198156</pub-id></element-citation></ref><ref id="B123-nutrients-17-02860"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gualano</surname><given-names>B.</given-names></name><name name-style="western"><surname>de Salles Painelli</surname><given-names>V.</given-names></name><name name-style="western"><surname>Roschel</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lugaresi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Dorea</surname><given-names>E.</given-names></name><name name-style="western"><surname>Artioli</surname><given-names>G.G.</given-names></name><name name-style="western"><surname>Lima</surname><given-names>F.R.</given-names></name><name name-style="western"><surname>da Silva</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Cunha</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Seguro</surname><given-names>A.C.</given-names></name><etal/></person-group><article-title>Creatine supplementation does not impair kidney function in type 2 diabetic patients: A randomized, double-blind, placebo-controlled, clinical trial</article-title><source>Eur. J. Appl. Physiol.</source><year>2011</year><volume>111</volume><fpage>749</fpage><lpage>756</lpage><pub-id pub-id-type="doi">10.1007/s00421-010-1676-3</pub-id><pub-id pub-id-type="pmid">20976468</pub-id></element-citation></ref><ref id="B124-nutrients-17-02860"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chilibeck</surname><given-names>P.D.</given-names></name><name name-style="western"><surname>Candow</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Landeryou</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kaviani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Paus-Jenssen</surname><given-names>L.</given-names></name></person-group><article-title>Effects of Creatine and Resistance Training on Bone Health in Postmenopausal Women</article-title><source>Med. Sci. Sports Exerc.</source><year>2015</year><volume>47</volume><fpage>1587</fpage><lpage>1595</lpage><pub-id pub-id-type="doi">10.1249/MSS.0000000000000571</pub-id><pub-id pub-id-type="pmid">25386713</pub-id></element-citation></ref><ref id="B125-nutrients-17-02860"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martimbianco</surname><given-names>A.L.C.</given-names></name><name name-style="western"><surname>de Sousa</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Nakata</surname><given-names>M.T.K.</given-names></name><name name-style="western"><surname>Baldini</surname><given-names>C.E.S.</given-names></name><name name-style="western"><surname>de Oliveira-Sales</surname><given-names>E.B.</given-names></name><name name-style="western"><surname>Boim</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Maquigussa</surname><given-names>E.</given-names></name></person-group><article-title>Creatine Supplementation in Type 2 Diabetic Patients: A Systematic Review of Randomized Clinical Trials</article-title><source>Curr. Diabetes Rev.</source><year>2022</year><volume>18</volume><fpage>e120721194709</fpage><pub-id pub-id-type="doi">10.2174/1573399817666210712151737</pub-id><pub-id pub-id-type="pmid">34931982</pub-id></element-citation></ref><ref id="B126-nutrients-17-02860"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elosegui</surname><given-names>S.</given-names></name><name name-style="western"><surname>L&#243;pez-Seoane</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mart&#237;nez-Ferr&#225;n</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pareja-Galeano</surname><given-names>H.</given-names></name></person-group><article-title>Interaction Between Caffeine and Creatine When Used as Concurrent Ergogenic Supplements: A Systematic Review</article-title><source>Int. J. Sport Nutr. Exerc. Metab.</source><year>2022</year><volume>32</volume><fpage>285</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1123/ijsnem.2021-0262</pub-id><pub-id pub-id-type="pmid">35016154</pub-id></element-citation></ref><ref id="B127-nutrients-17-02860"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trexler</surname><given-names>E.T.</given-names></name><name name-style="western"><surname>Smith-Ryan</surname><given-names>A.E.</given-names></name></person-group><article-title>Creatine and Caffeine: Considerations for Concurrent Supplementation</article-title><source>Int. J. Sport Nutr. Exerc. Metab.</source><year>2015</year><volume>25</volume><fpage>607</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.1123/ijsnem.2014-0193</pub-id><pub-id pub-id-type="pmid">26219105</pub-id></element-citation></ref><ref id="B128-nutrients-17-02860"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vanakoski</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kosunen</surname><given-names>V.</given-names></name><name name-style="western"><surname>Meririnne</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sepp&#228;l&#228;</surname><given-names>T.</given-names></name></person-group><article-title>Creatine and caffeine in anaerobic and aerobic exercise: Effects on physical performance and pharmacokinetic considerations</article-title><source>Int. J. Clin. Pharmacol. Ther</source><year>1998</year><volume>36</volume><fpage>258</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">9629989</pub-id></element-citation></ref><ref id="B129-nutrients-17-02860"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Green</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Hultman</surname><given-names>E.</given-names></name><name name-style="western"><surname>Macdonald</surname><given-names>I.A.</given-names></name><name name-style="western"><surname>Sewell</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Greenhaff</surname><given-names>P.L.</given-names></name></person-group><article-title>Carbohydrate ingestion augments skeletal muscle creatine accumulation during creatine supplementation in humans</article-title><source>Am. J. Physiol. Metab.</source><year>1996</year><volume>271</volume><issue-part>Pt 1</issue-part><fpage>E821</fpage><lpage>E826</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.1996.271.5.E821</pub-id><pub-id pub-id-type="pmid">8944667</pub-id></element-citation></ref><ref id="B130-nutrients-17-02860"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steenge</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Lambourne</surname><given-names>J.</given-names></name><name name-style="western"><surname>Casey</surname><given-names>A.</given-names></name><name name-style="western"><surname>Macdonald</surname><given-names>I.A.</given-names></name><name name-style="western"><surname>Greenhaff</surname><given-names>P.L.</given-names></name></person-group><article-title>Stimulatory effect of insulin on creatine accumulation in human skeletal muscle</article-title><source>Am. J. Physiol. Metab.</source><year>1998</year><volume>275</volume><fpage>E974</fpage><lpage>E979</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.1998.275.6.E974</pub-id><pub-id pub-id-type="pmid">9843739</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="nutrients-17-02860-f001" orientation="portrait"><label>Figure 1</label><caption><p>Synergistic effects of creatine supplementation and exercise on glucose metabolism and sarcopenia prevention in type 2 diabetes. (<bold>a</bold>) Healthy skeletal muscle: adequate muscle mass with efficient insulin-mediated GLUT4 translocation for glucose uptake. (<bold>b</bold>) Type 2 diabetes with sarcopenia: reduced muscle mass, chronic inflammation, impaired glucose uptake, and mitochondrial dysfunction. (<bold>c</bold>) Interventions: combined resistance/aerobic exercise and creatine monohydrate supplementation increase GLUT4 expression, glycogen storage, and mitochondrial activity while reducing oxidative stress. (<bold>d</bold>) Clinical outcomes: improved muscle strength and mass, enhanced glucose metabolism, and reduced HbA1c levels.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02860-g001.jpg"/></fig><fig position="float" id="nutrients-17-02860-f002" orientation="portrait"><label>Figure 2</label><caption><p>GLUT4 activation by insulin and muscle contraction.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nutrients-17-02860-g002.jpg"/></fig><table-wrap position="float" id="nutrients-17-02860-t001" orientation="portrait"><object-id pub-id-type="pii">nutrients-17-02860-t001_Table 1</object-id><label>Table 1</label><caption><p>Summary of randomized and controlled trials of creatine + exercise, including studies in T2D, older adults, and healthy volunteers.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Design</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">N</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Population (Mean Age)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Intervention&#8212;Creatine (Form, Dose, Scheme) + Exercise (Type, Freq, Intensity)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Comparator</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Duration</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Metabolic Outcomes (Direction; Significance)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Muscle Outcomes (Lean Mass, Strength, Function)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Safety/Renal Markers</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Op&#8217;t Eijnde B et al., 2001 [<xref rid="B23-nutrients-17-02860" ref-type="bibr">23</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DBPC RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healthy volunteers (immobilization model)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CrM during immobilization + rehabilitation; resistance rehabilitation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Placebo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 weeks immobilization + 10 weeks rehabilitation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8593; GLUT4 preservation/&#8593; GLUT4 during rehabilitation(vs placebo)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8593; GLUT4 and glycogen recovery with retraining</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No safety signals reported</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Derave W et al., 2003 [<xref rid="B90-nutrients-17-02860" ref-type="bibr">90</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DBPC RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healthy adults (one-leg immobilization)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CrM &#177; protein during immobilization/retraining; localized resistance retraining</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Placebo/creatine arms</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 weeks immobilization + 6 weeks retraining</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8593; glycogen and improved GLUT4 recovery when CrM + protein + retraining</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8593; muscle glycogen; &#8593; GLUT4 with activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No adverse renal effects reported</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gualano B et al., 2008 [<xref rid="B91-nutrients-17-02860" ref-type="bibr">91</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT DBPC (aerobic trial)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sedentary healthy males</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CrM + moderate-intensity aerobic training</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Placebo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Improved OGTT glucose response (significant); no change fasting insulin/HOMA-IR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8593; glycogen (no GLUT4 protein change)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No safety signals reported</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gualano B et al., 2011 [<xref rid="B22-nutrients-17-02860" ref-type="bibr">22</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT DBPC (T2D)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adults with T2D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CrM 5 g/day + combined aerobic + resistance (3&#215;/wk)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Placebo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8595; HbA1c and &#8595; meal glycemia (significant); insulin/C-peptide unchanged</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Functional/muscle benefits reported with training</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No detrimental changes in albuminuria/BUN/creatinine</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oliveira CLP et al., 2020 [<xref rid="B92-nutrients-17-02860" ref-type="bibr">92</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT DBPC pilot</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR (small)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Community-dwelling older adults</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CrM + resistance training (dose per paper)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Placebo + resistance training</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No significant change in fasting insulin or HOMA-IR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Variable muscle improvements; inconsistent additive benefit</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No renal/hepatic adverse effects reported</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alves CR et al., 2012 [<xref rid="B93-nutrients-17-02860" ref-type="bibr">93</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mechanistic RCT/trial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Individuals with T2D/mechanistic samples</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CrM supplementation (dose per paper) &#177; exercise</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Placebo/control</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Short term</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AMPK&#945; activation signals correlated with GLUT4 translocation (suggested)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not primary for clinical muscle endpoints</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No safety concerns reported</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Collins J et al., 2016 [<xref rid="B94-nutrients-17-02860" ref-type="bibr">94</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pilot RCT/cohort</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Frail older adults (70 &#177; 5 y)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CrM 5 g/day + protein + resistance training</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein + resistance training</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Metabolic markers not significantly altered</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8593; Strength; no adverse muscle damage markers</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No changes in renal/hepatic markers reported</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Newman JE et al., 2003 [<xref rid="B95-nutrients-17-02860" ref-type="bibr">95</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCTs (negative/mixed)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Small samples</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healthy males</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CrM (standard protocols) &#177; training</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Placebo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Short term</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No consistent effects on insulin sensitivity/fasting insulin/HOMA-IR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8593; glycogen (van Loon) but no GLUT4 protein increase; mixed strength effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No safety signals</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">van Loon LJ et al., 2004 [<xref rid="B96-nutrients-17-02860" ref-type="bibr">96</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NRCT DBPC </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Small samples</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healthy males</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CrM (standard protocols) &#177; training</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Placebo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 weeks</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No consistent effects on fasting insulin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8593; glycogen but no GLUT4 protein increase</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No safety signals</td></tr></tbody></table><table-wrap-foot><fn><p>Footnotes: DBPC, double-blind placebo-controlled; RCT, randomized controlled trial; CrM, creatine monohydrate; GLUT4, glucose transporter type 4; OGTT, oral glucose tolerance test; HOMA-IR, homeostatic model assessment of insulin resistance; T2D, type 2 diabetes; AMPK&#945;, AMP-activated protein kinase alpha subunit; BUN, blood urea nitrogen; NR, not reported; y, years; g/day, grams per day; &#215;/wk, times per week. Arrows (&#8593;, &#8595;) indicate increase or decrease, respectively. Only two trials were conducted in patients with T2D; the remaining studies involved older adults, healthy volunteers, or experimental immobilization models.</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>